THE INVOLVEMENT OF BREAST CANCER PATIENTS AND FAMILY MEMBERS DURING ONCOLOGICAL CONSULTATIONS.
A STUDY TO EXPLORE THE INFORMATION NEEDS AND TO ASSESS THE EFFECTS OF A PRE-CONSULTATION INTERVENTION TO INCREASE THE PATIENTS INVOLVEMENT IN THE INFORMATION EXCHANGE. by Alessandro Bottacini
UNIVERSITÀ DEGLI STUDI DI VERONA 
 
 
DEPARTMENT OF  
 
PUBLIC HEALTH AND COMMUNITY MEDICINE 
 
GRADUATE SCHOOL OF 
 
SCIENCES ENGINEERING MEDICINE  
 
 
DOCTORAL PROGRAM IN  
 
PSYCHOLOGICAL AND PSYCHIATRIC SCIENCES 
 
 
Cycle: XXVII 
 
 
 
TITLE OF THE DOCTORAL THESIS 
 
THE INVOLVEMENT OF BREAST CANCER PATIENTS AND FAMILY 
MEMBERS DURING ONCOLOGICAL CONSULTATIONS 
A STUDY TO EXPLORE THE INFORMATION NEEDS AND TO ASSESS THE 
EFFECTS OF A PRE-CONSULTATION INTERVENTION TO INCREASE THE 
PATIENTS INVOLVEMENT IN THE INFORMATION EXCHANGE 
 
 
S.S.D. PSI-08 
 
 
 
Coordinator:   
Prof.ssa MIRELLA RUGGERI 
Department of Public Health and Community Medicine 
Section of Psychiatry 
 
  
Tutor:    
Dott.ssa CLAUDIA GOSS 
Department of Public Health and Community Medicine 
Section of Clinical Psychology   
       
 
Doctoral Student:  
Dott. ALESSANDRO BOTTACINI 
Department of Public Health and Community Medicine 
Section of Clinical Psychology 
ABSTRACT 
 
 
 
Background: The interest in communication issues regarding cancer care has steadily 
increased, in particular concerning the information needs of oncology patients. Studies on 
patient involvement show that physicians make few attempts to involve their patients who ask 
few questions if not facilitated. On the other hand, patients who participate in the decision 
making process show greater treatment adherence and have better health outcomes. Two main 
intervention techniques have been tested in an attempt to make patients more aware about their 
needs and to encourage them to make more questions during the consultation. Firstly, they have 
been encouraged, though a coaching process to generate their own list of questions. Secondly 
patients have been provided with a structured pre-prepared list of evidence based questions, a 
Question Prompt Sheet (QPS). 
Aims: The aim of this study is to assess the effects of a pre-consultation structured intervention 
(QPS) compare to a simple intervention (QL) to increase the involvement of breast cancer 
patients by determining an increase in questioning. 
Methods: All patients with breast cancer who attend the Oncology Out-patient Services for the 
first time are randomly assigned to one of the two intervention groups. The intervention consists 
of the presentation of a list of relevant illness-related questions (QPS) or a request to generate a 
list of relevant questions (QL) before the consultation. Standardised questionnaires are 
administered at baseline (before the randomisation) and immediately after the consultation. 
The main outcome measure is the number of questions asked by patients during the consultation 
Results: Among all patients (537), 143 were excluded for exclusion criteria. Of the 394 eligible 
patients, 70 refused to participate in the study, so that the remaining 324 patients, 164 were 
assigned to the QPS group and 160 to the QL, according to the randomization. 16 audiotapes 
were lost due to technical reasons so that the final sample comprised 308 patients with complete 
data: 158 and 150 respectively in the QPS and QL group.  
All Patient asked an average of 14 questions. Patients in the QPS group asked an average of 13 
while in the QL group they asked an average of 16 questions. The difference between pooled 
arms was statistically significant (t (271) = – 1.99, p = .05). The effect of hierarchical structure of 
the sample was measured by intra-class correlation (ICC). The results obtained by the mixed 
linear model, taking into account the hierarchical structure, show that the difference between 
interventions lost its significance (b = 1.7; 95%; CI: – .29; 3.64. p = 9%). 
Discussion: In our study we compared QPS to an open-ended question (QL) in the other group 
which can have played an important role as well as the QPS in preparing patients, prior the 
consultation, to focus better their attention to what they wish to ask their oncologist. Preparing 
patients for the consultation (using QPS or a QL as well) is a quick and simple way to promote 
patients asking questions and may improve the overall communication between oncologist and 
patient.
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1. THEORETICAL OVERVIEW 
 
 
1.1 Doctor-patient communication 
 
Among inter-personal relationships, the doctor-patient relation is one of the most 
complex because it involves interaction between individuals who seem to be in non-
equal positions, is often non-voluntary, concerns issues of vital importance, is therefore 
emotionally laden, and requires close cooperation. It is also well known that certain 
aspects of doctor-patient communication have an influence on patients’ behavior and 
well-being, such as satisfaction with care, adherence to treatment, recall and 
understanding of medical information, coping with the disease, quality of life, and even 
state of health (Ong et al., 1995). 
Doctor-patient communication becomes even more important in cancer care 
where there is the need to give information in a sensitive way to patients that are often 
anxious and worried about their prognosis. Although cancer communication has much 
in common with communication in other health contexts, several unique elements of 
cancer care make cancer communication research important: a) few other illness are 
both life-threatening and potentially curable; b) it involves numerous clinicians and 
multiple treatment modalities (such as oral and intravenous medications, radiation, and 
surgery); c) there is often a long period of uncertainty after treatment, and d) the 
patient’s health care team often changes over time (Epstein & Street, 2007). 
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1.2 Patient involvement 
 
In the last decades something has changed in the doctor-patient relationship due to the 
fact that patients want more information concerning their illness and its management 
(Jekins et al., 2001). They want a greater involvement in treatment decisions, so they 
tend to prefer a more active role in the decision making process regarding their illness, 
especially in oncology. 
Though, cancer patients’ preferences for information and decisional involvement 
vary, meeting these preferences is a complex communication task. It has been observed 
that what the physician says has an immediate effect on what the patient says and 
therefore can influence the degree of patient participation in the consultation (Charles et 
al., 2000; Drew et al., 2001; Zimmermann et al., 2003). 
Although patients want to be more involved, they cannot express their treatment 
preferences and participate in decisions unless they are given sufficient and appropriate 
information. Therefore, the greatest attention has to be given to their concerns and their 
information requests and preferences. The discrepancies between physicians and 
patients’ perception of information needs can be an important barrier to providing 
patients with appropriate information during the medical consultation. In spite of 
evidence-based requests (Fallowfield et al., 1994; Gattellari et al., 2001; Brown et al., 
2012) to routinely involve patients in decision making (Breitsameter, 2010; Charles and 
Gafni, 2010; Siminoff, 2010), patients are often not involved in decision making 
(Albrecht et al., 2003a; 2003b; Brown et al., 2004) and their preferences are not being 
met (Brown et al., 2007; Gattellari et al., 2001; Ford et al., 2003; Bilodeau & Degner, 
1996; Sutherland et al., 1989; Brown et al., 2010). Information needs in heath is a 
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concept that is well defined based on theories derived from information science. 
Information needs emerge because of an underlying dissatisfaction with the existing 
situation and/or deficiency in a person’s knowledge defined and recognized by the 
individual, motivating the person to seek answers and form questions to find a solution 
for a particular problem (Ormandy, 2011). 
The evidence indicates that patient’s preferences for the type and amount of 
information vary. Moreover the information needs of patients with cancer differ among 
patients, change over time (Cegala, 2003), vary depending on the type and stage of 
cancer, and persist throughout the cancer care continuum. This requires physicians to 
adapt the information giving process to the needs and to the level of comprehension of 
the single patient. If the expression of such needs is not facilitated or encouraged, these 
needs tend to remain hidden, with the risk that patient perceives the received 
information as either too much or too little. Good clinical practice entails the 
recognition of variations in patient’s preferences, and helping patients accomplish these 
preferences. When physician meets patient’s information preferences, patient is better 
able to handle the information in a way that fits him/her best, which is associated with 
better quality of care, coping with illness and treatment adherence (Joosten et al., 2008).  
 
 
1.3 Respective Roles 
 
Historically, the clinician’s role was to provide disease-related information and 
recommendations, and the patient’s role was to share symptoms and concerns, but 
important changes have occurred in the process of information exchange over the past 
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four decades. The role of patient in the consultation has changed, leaving a paternalistic 
approach where doctor directs care and makes decisions about treatment while patient 
remains passive, delivering his or her health into the hands of the doctor. In a more 
balanced way of view, the patient assumes the role of an expert himself: while 
physicians know the causes of disease, the diagnostic instruments and the therapeutic 
interventions, patients know their habits, their own experience of disease and the impact 
that this one has on their lives and on the social context. So patients’ point of view and 
their preferences are increasingly being considered into their health assessment and 
treatment.  
 
 
1.4 Patient-centered approach and share decision-making 
 
The need to take into account these aspects has gradually enhanced the importance of 
what is called Patient-Centered Approach (Smith, 1997; Mead & Bower, 2000), in 
which the physician applies an active listening, formulates open questions, provides 
empathetic responses and encourages patient’s requests. Studies showed that patients 
tend to prefer a patient-centered approach and how this approach is very effective in 
both the information gathering phase and the final phase of the consultation, increasing 
the satisfaction and the chance of adherence to treatment (Little et al., 2001; Mead & 
Bower, 2002). The meeting between two experts who enables a better treatment 
outcome seems to be the key of success of the patient-centered medicine and the shared 
approach model, called shared decision-making (Coulter, 2002). 
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 The Shared Decision-Making (SDM)  is an approach in which clinicians and 
patients communicate together using the best available evidence when faced with the 
task of making decisions. Patients are supported to deliberate about the possible 
attributes and consequences of options, to arrive at informed preferences in making a 
determination about the best course of action which respects patient autonomy, as well 
as ethical and legal norms (Charles et al., 1997). 
Patient centered communication has become the gold standard for excellence in 
clinical communication. It consists of clinicians eliciting and understanding their 
patients’ perspectives and social contexts, reaching a shared understanding and 
empowering patients by offering meaningful involvement in treatments decisions (Del 
Piccolo and Goss, 2012).  
In a relationship where both, patients and physicians are at the same level, they 
have equal tasks to achieve patient-centered cancer care. Clinicians often are more 
informative, accommodative, and supportive with patients who are forthcoming with 
questions, concerns, opinions, and preferences (Street, 1992; Street, 1991; Brown et al., 
2002; Street et al. 2005). Similarly, if a patient with cancer is passive, a clinician could 
use partnering and other facilitative behavior such as asking for the patient’s opinion or 
concerns, or offering encouragement. Such behaviors generally elicit greater patient 
involvement because the clinician’s communication both legitimizes and specifically 
asks for the patient’s views (Street et al., 1995; Street et al., 2003). 
However this mutual influence is often below the level of awareness. Clinicians 
must improve the ability to monitor and consciously adapt communication to meet the 
patient’s needs. A second important issue is discovering the way in which patients want 
to be involved in decision-making. Clinicians are not particularly good judges of 
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patients’ preferences for involvement in decision-making in the cancer setting (Bruera 
et al., 2002; Bruera et al., 2001)
. 
Thus, it is important to identify these preferences and 
make appropriate adaptations. An oncologist who routinely solicits and encourages 
patient involvement in decision-making, may take more responsibility if he or she 
senses that the patient wants this. This clinician may still actively encourage the patient 
to talk about his or her concerns, however. Conversely, clinicians who have limited 
perceptiveness or a fixed communication style will have less adaptability and will find 
they interact with some patients effectively but have considerable difficulty with others.  
In situations characterized by high levels of physical discomfort, anxiety, 
cognitive complexity, and/or ambiguity, the same patient may become overwhelmed 
because the cognitive and emotional burden exceeds his or her capacity to adapt to the 
requirements of the situation. In those cases, clinicians may need to adopt a different 
communication style than would ordinarily work well for that patient. Similarly, 
clinicians can become overwhelmed, and as a result, distance themselves from the 
patient and fail to elicit and respond to the patient’s needs. In addition, clinicians must 
help patients filter and understand clinical information, a sine qua non for informed or 
participatory decision-making (Blanchard et al., 1988; Kim et al., 2001). 
On the other hand patients must communicate in a way that reveals their needs, 
preferences, expectations, concerns, and perspectives. Particularly important are active 
communication behaviors such as asking questions, expressing concerns, being 
assertive in stating opinions and preferences, introducing topics for discussion, and 
telling their “health stories” (Street, 2001). By contrast, a patient who remains passive 
during the interaction does little to convey his or her needs, fears, expectations, beliefs, 
and preferences. Health outcomes may be at risk in these situations, and the encounter 
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will not satisfy the patient’s need to feel known, understood, or heard or satisfy the 
clinician’s moral obligation to address the patient’s underlying concerns in order to 
maximize healing. 
Regardless of their preferences for the clinician’s communication style, patients 
and their families generally want to be involved in the process of care, be informed of 
all the treatment options, feel listened to, and feel that their physicians know them as 
people, not simply diseases (Henman et al., 2002; Thorne et al., 2005). In order to be 
involved and to feel understood, patients must be able to effectively and actively 
communicate their needs, concerns, and perspectives. 
 
 
1.5 Interventions 
 
Effectively the focus of many studies has been recently directed towards the patient 
activation to be more involved in the consultation and in treatment decision (Clayton et 
al., 2007). One way to increase activation is by encouraging patients to ask questions. 
The number of questions asked by patients can be considered a first index of active 
participation in the discussion and an expression, at the same time, of patient’s most 
immediate information needs (Butow et al., 2002; Eggly et al., 2006; Ellis et al.,1999; 
Parker et al., 2003; Siminoff et al., 2000). Patients who actively participate in 
consultations by asking questions are able to change the focus of the consultation and 
control the duration and the amount of information provided by their physicians 
(Kaplan et al., 1996). Thus, by enabling patients to ask questions that concern them, 
doctor-patient communication may be improved (Street, 2001). Interventions to increase 
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the number of questions by the patient have pointed out that, with the rise of this 
number, the quality of the information exchange between physician and patient 
improves in turn (Eggly et al., 2006; Brown et al., 2001; Butow et al., 1994; Clayton et 
al., 2007). 
Two main intervention techniques have been tested in an attempt to make 
patients more aware about their needs and to encourage them to make more questions 
during the consultation. Firstly, patients have been encouraged, though a coaching 
process with an independent assistant to generate their own list of questions (Jones et 
al., 2002) about their cancer and treatment options (Belkora et al., 2008; Kidd et al., 
2004; Sepucha et al., 2000) During coaching, patients have the opportunity to rehearse 
their questions in preparation for their consultation. A consultation plan is then 
generated and provide to the patient, family members and the physician to be used as a 
visual aid during the consultation (Belkora et al., 2006). Secondly patients have been 
provided with a pre prepared list of evidence based questions, a Question Prompt Sheet 
(QPS). QPSs are structured lists of prepared questions that prompt patients to consider 
novel topics before an oncology consultation to stimulate patients to raise these with 
their physician or to use the QPS as a reminder (Brown et al., 2001; Butow et al., 1994; 
Clayton et al., 2007; Brown et al., 1999; Bruera et al., 2003). Prior to a consultation, 
patients are provided with a QPS and asked to circle questions they would like to ask. 
Patients are then encouraged to take the QPS into the consultation and ask their chosen 
questions, including other questions as they arise. Formative work in the oncology 
setting demonstrated that using the QPS, coupled with physician endorsement of 
question asking, a) encouraged patients to ask questions about sensitive and difficult 
topics such as prognosis, diagnosis, and issues surrounding end of life care (Brown et 
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al., 2001; Clayton et al., 2007; Brown et al., 1999) and b) improved patient outcomes 
(Brown et al., 2001; Clayton et al., 2007; Brown et al., 199; Kinnersley et al., 2008, 
Roter, 1977). 
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2. OBSERVATIONAL PHASE 
 
2.1 Aims 
 
The experimental phase has been preceded by an observational phase with the aim to  
assess the sample characteristics and the ongoing hospital setting. It has been described 
in a paper “in press” on the European Journal of Oncology Nursing.  
 
 
 
 
2.2 Methods 
 
2.2.1 Setting 
 
Patients were recruited during the first six months of 2010 in the outpatient clinic of the 
Medical Oncology Unit of the “Ospedale Civile Maggiore”, Hospital Trust of Verona in 
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the Veneto region, Italy. This hospital has an outpatient clinic dedicated to patients with 
breast cancer, with a rotation of 2–5 oncologists and it has been chosen due to its 
association with the “Gruppo Senologico Veronese” (GSV). The GSV members adopt a 
multi-disciplinary approach to breast cancer in order to offer a personalized care, from 
prevention through diagnosis, treatment, and post treatment support. 
Visits for breast cancer patients were scheduled on fixed weekdays, from four to eight 
patients a day. Patients have already been diagnosed with cancer, often have undergone 
the first breast surgery (e.g. lumpectomy) and were referred to the medical oncologist 
by the surgeon or by the radiologist. Generally, in the first visit with the medical 
oncologist the aim was to communicate the histological results and to decide further 
medical treatments (e.g. chemotherapy or hormone therapy). The consultation could 
vary from 30 to 60 min. Eligible patients were all female patients with an age between 
18 and 75 years old, with a recent diagnosis of breast cancer at an early stage. Exclusion 
criteria were the presence of metastasis or relapse, severe mental deterioration and a 
difficult comprehension of Italian language. 
 
 
2.2.2 Data collection procedure 
 
Oncologists informed consent to participate and socio-demographic data were collected 
at the beginning of the study. 
On fixed days the oncology nurses, in accordance with the oncologists, gave to the 
researcher a list of scheduled patients. At the department waiting room, all consecutive 
breast cancer patients at their first out-patient visit with the oncologist were asked to 
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give written informed consent to participate in the study. Consenting patients were then 
accompanied to a dedicated room where they received an envelope containing five 
questionnaires to complete before the consultation. Consultations were performed as 
usual by oncologists according to their clinical practice and were audio-recorded. Just 
the recording device was present during the consultation and it was managed 
independently by the oncologists. After the consultation, patients returned to the 
researcher and completed three other questionnaires. Oncologists reported on a form the 
cancer stage and type, when the patient had been informed about diagnosis and the 
therapeutic options appropriate for each patient. The local ethic committee approved the 
study. 
 
 
2.2.3 Pre-consultation measures 
 
Socio-demographic and clinical data collected were age, education, family status, 
employment status, cancer stage and time since diagnosis. Consultation characteristics 
collected were presence of a relative or companion, type of treatment prescription and 
consultation length, including the doctor–patient communication attitude of the 
oncologist, measured with the Doctor-Patient (DP)Scale (De Monchy et al.,1988). The 
instrument has 48 items, with an average score of 1 indicating a “doctor centered-
disease oriented ”attitude and an average score of 5 indicating a “patient centered 
problem oriented” attitude. Other variables likely to be associated with patients' 
expressed information needs were assessed with the following instruments: 
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- the State-Trait Anxiety Inventory (STAI-X1) (Spielberger et al.,1983) assessing the 
level of anxiety; 
- the Patient Health Questionnaire depression scale (PHQ-9) (Kroenke et al., 2001) 
detecting the presence of depression; 
- the General Health Questionnaire (GHQ-12) (Politi et al., 1994)indicating 
psychological distress; 
- the Control Preference Scale (CPS) (Giordano et al., 2008) measures patients' 
preferences in the shared decision making process. 
- the Decision Self Efficacy Scale (DSES) (O'Connor, 1995) measuring patients' 
confidence to make an informed decision. 
 
 
2.2.4 Post-consultation measures 
 
After the consultation patients complete other three questionnaires: 
- the Patient Enablement Instrument (PEI) (Howie et al., 1998) assessing the ability to 
cope with the illness; 
- the Shared Decision Making Questionnaire (SDM-Q) (Simon et al., 2006) 
measuring the degree that patients felt to be involved in decisions during the 
consultation 
- the Satisfaction With Decision scale (SWD) (Holmes-Rovner et al., 1996) 
measuring patients' satisfaction with decisions made during the consultation; 
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Oncologists complete also the Control Preference Scale (CPS). 
- the Oncologist version of the CPS evaluates if oncologists guess the role preferred 
by patients during the consultation. The agreement between patients role preferences 
and oncologists perception was calculated and used as a new variable. 
 
 
2.2.5 Audiotapes analysis 
 
The audio-recorded consultations were examined for the conversation length and for the 
content and number of questions asked by patients. Questions were defined as 
“utterances in interrogative form that ask for information or clarification” (Street et al., 
2007). 
Three researchers were involved in the coding process. They identified the five 
main question categories (symptoms, etiology, prognosis, prevention and illness 
management) starting from those described in the literature (Jenkins et al., 2001; Brown 
et al., 2001). A sixth category was added to account for administrative questions. 
The illness management category was split then into five other sub-categories: a) 
treatments specific for breast cancer, including administration, duration, frequency, 
effectiveness of the therapies (e.g. chemotherapy, hormone therapy, immunotherapy, 
surgery; b) side effects of treatment; c) check-ups and follow-up visits (e.g. 
mammography, blood tests); d) other pharmacological treatments related to pathologies 
in co-morbidity; and e) others not specified elsewhere. 
Inter-rater reliability among the three coders was calculated on ten consultations, 
revealing an average percentage agreement of 62.9% and a Cohen's kappa of 0.49, 
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which are acceptable according to Landis and Koch (1977). Subsequently, listening to 
the audiotapes, all direct questions of patients were identified, transcribed verbatim and 
categorized using the categories previously identified. 
 
 
2.2.6 Statistics 
 
The scores of the scales listed above were tested for their association with patients' 
information needs (specifically, the number of questions per interview for each 
category) using Chi-squared test or Pearson's correlation coefficients where appropriate. 
Kolmogorov-Smirnov, or chi square median test for equality of frequency distribution, 
were performed when no normality assumptions could be made. The analyses were 
performed on valid cases, using Stata 11.2 (StataCorp, 2011). 
 
 
2.3 Observational Results 
 
2.3.1 Sample and consultation characteristics 
 
Of the 95 eligible patients, 18 (19%) refused to participate in the study due to several 
reasons such as high anxiety or hurry to see the physician. Of the remaining 77 audio-
recorded consultations, seven consultations (9%) were lost due to technical problems, 
the final sample therefore consisted of 70 patients (see flow-diagram). 
21 
 
About socio-demographic data, patient's average age was 58 (± 9.7, range 31-
75). Most patients were married (63%) with children(81%) and had at least 8 years of 
education (78%). 41% of patients were employed, 34% were retired and 23% were 
housewives. 
Forty-eight patients (69%) attended with a relative who joined the consultation. 
 
Flow diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients at first consultation 
(n =77) 
Patients analyzed 
(n = 70) 
Patients with companions   (n = 49) (70%) 
Companions    (n = 51) 
Patients lost due to technical 
reasons 
(n = 7) (9%) 
Ineligible patients 
(n = 55, 37%) 
Age ≥ 75 (n = 35) 
Language (n =   2) 
Metastasis (n =   0)  
Relapse (n = 18) 
 
Patients accessed for eligibility 
(N = 150) 
Refusals 
(n = 18) (19%) 
Eligible 
(n = 95) 
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Regarding the clinical data, twenty-two patients (32%) had a carcinoma in situ, 28 
(40%) had cancer at stage I, 17 (24%) at stage II and 3 (4%) at stage III. Average time 
since the communication of diagnosis was two months (average 2.3 ± 1.11; range = 0-
5). 14% patients did not receive any treatment prescription during the consultation, 22% 
received one, and 64% two or more prescriptions. 
The oncologist prescribed chemotherapy 19 times (27%), radiotherapy 46 times (66%), 
hormone therapy 47 (67%) and immunotherapy 6 times (8%). 
Oncologist 1 and 2 (female) contributed with 52 and 13 consultations respectively, 
while Oncologist 3 (male) contributed with 4 consultations. Oncologists 1 and 3 
reported a doctor-centered attitude on the DP questionnaire (average score of 2.3 for 
both), while Oncologist 2 reported a balanced attitude (DP average score of 2.9). 
Oncologists stated that nearly two third of patients (59%) preferred a shared approach, 
7% a very or active role and 34% a passive or a very passive role. In half of the cases 
(55%) the oncologists correctly identified patients' preference regarding their role in 
making medical decisions (46%, 61% and 25% for Oncologist 1, 2 and 3 respectively). 
The average consultation length was 34 min (±12.5, range 12-72). 
 
 
2.3.2 Psychological patient characteristics 
 
Before the consultation patients were slightly anxious (STAI-X1), 33% were depressed 
(PHQ-9) and 64% were emotionally distressed (GHQ-12). More than half of patients 
reported (on the CPS) to prefer a shared medical decision with the oncologist, a 
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minority preferred an active role, and about one third preferred a passive or a very 
passive role. 
Before the consultation patients were reasonably confident in treatment decision 
(DSES), and after the consultation they stated that the oncologist had been good 
enough, helping them in the decision making process (SDMQ). They reported a high 
satisfaction with decision (SWD), and said to be somewhat better equipped to cope with 
their illness than before the consultation (PEI). 
 
 
2.3.3 Patients' information requests 
 
Patients asked an average of 17.6 questions. Excluding administrative questions, the 
average dropped to 11.8 questions (± 8.6, range 0-39). The topics were mostly related to 
illness management, particularly treatment, and administrative procedures. In contrast, 
patients asked fewer questions about prognosis, prevention and etiology. Sixty-five 
patients (93%) asked at least one question about illness management and one question 
about administrative procedures. Fifty patients (71%) asked at least one question about 
symptoms. Most patients asked no questions on etiology or prevention (86% and 70% 
respectively). Half of patients (51%) asked no questions about prognosis. Only one 
patient asked no questions at all: she was 71 years old, widow, graduate, retired and 
mildly depressed (PHQ = 8). Her daughter was present at the consultation and asked 
seven questions. Other four patients (66, 49, 73 and 75 years old) asked no questions 
about illness management. 
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2.3.4 Variables affecting question asking 
 
Only significant associations are reported here. Satisfaction With the Decision (SWD) 
questionnaire was not included among the explorative factors due to its lack of 
discriminatory power. A greater number of questions were associated with being 
employed instead of not been employed (M = 21 ± 10.5 and M = 15 ± 10.9 respectively) 
(t = .32; p = .04). A greater number of questions about illness management, particularly 
about the side effects of radiotherapy, were related to younger age (r = .28, p = .01 and 
r = .24, p = .05 respectively). Questions also increased with consultation time (r = .47, p 
< .01), particularly those about illness management (r = .5, p < .01) and administrative 
topics (r = .27, p = .02). We explored this finding using cut-off score of 30 min, as it 
was the scheduled time of the first consultation. 
Thirty-three consultations took less than 30 min with an average of 13 questions asked 
by patients (± 7.4 range 0-32) while 37 consultations took more than 30 min with an 
average of 21 questions (± 12.4, range 1-49, t(59.86) = 3.31, p < .01). 
Patients who were prescribed chemo-therapy asked more questions than those without 
(M = 25, ± 13.5, range 8-49 vs. M = 15, ± 8.4, range 0-35; t(23.45) = 3.17, p < .01), 
particularly questions on chemotherapy (M = 8, ± 4.8, range 0-16 vs. M = 3, ± 2.7, 
range 0-12; t(22.14) = 3.76, p < .01) and its side effects (M = 5, ± 3.6; range 1-13 vs. M = 
2, ± 1.9, range 0-7; t(22.15) = 3.57, p < .01). 
The longer the time patients knew their diagnosis, the more questions they asked on 
prevention (r = .25, p = .05). 
Patients seen by the two oncologists, who favored a doctor-centered approach, asked 
fewer questions compared to the 14 patients seen by the “balanced” oncologist (M = 13, 
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± 6.3 and 19, ± 11.9 respectively; t(56.49) = 2.81, p < 0.01). Question asking also 
increased when the oncologist guessed correctly the patient's preferred role in the 
decision making process (19.5, ± 10.9 vs. 15.5, ± 11.1; chi square median test = 5.47, p 
= .02). 
A greater patients self-rated ability to cope with illness (PEI) significantly reduced 
questions about symptoms and illness management(r = .26, p = .04 and r = .28, p = .02, 
respectively). 
 
 
2.4 Considerations 
 
As observational study it has some limitations beside some strengths. One limitation 
that has to be considered is that these data only permit analysis at the cross-sectional 
level, which do not allow to make strong causal claims. Furthermore the relatively small 
sample size reduces the possibility to detect significant relationships and does not allow 
the assessment of interaction effects on question asking. Moreover, the presence of a 
recorder in the consultation could be a limit. Patients who did not want to be audio 
recorded (n = 3) were excluded from the sample, so this could introduce a selection bias 
although the sample representativity seems to be not compromised. The recorder might 
have had also a bias effect on patient behavior. If so, we think that it could be very 
slightly for two reasons. Firstly, the device had small dimensions and remained out of 
sight in a position that did not attract patients' attention. Secondly, analyzing the 
recorded consultations, no patients expressed a particular bother concerning the device, 
so we could say that its presence was almost forgotten. 
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However this study has a homogeneous sample available, which limited the 
possible confounding factors effect related to settings and service organization. This 
homogeneity has reduced also the findings variability, due to the oncologists and this 
has to be considered a strength.   
Regarding question asking, patients asked an average of 18 questions, confirming 
previous findings in literature (Jenkins et al., 2001; Finney Rutten et al., 2005), even 
though Italian breast cancer patients seem to ask slightly more questions. 
As observed before in other countries, the most frequently occurring questions were 
related to illness management in terms of treatment (Jenkins et al., 2001; Finney Rutten 
et al., 2005). These findings are not surprising as the primary purpose of the first 
oncology consultation is to suggest and discuss treatment options. Unexpectedly, the 
second most frequent topic were related to administrative procedures. Many information 
requests for administrative procedures addressed to the oncologist take away precious 
consultation time, and signal the lack of written directives to anticipate and to meet such 
predictable needs in a more appropriate manner. 
Univariate comparisons and Pearson's correlations give some first indications of 
the variables likely to affect the number and types of questions in this sample. As 
reported before (Kinnersley et al., 2008), reduced question asking was associated with 
shorter consultations. 
Contrary to previous findings (de Bock et al., 2004), emotional distress, anxiety 
and depression levels were not associated with information requests, despite in our 
sample, the presence of psychosocial distress was similar to what was observed in other 
countries (Kissane et al., 2004; Gallagher et al., 2002). 
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3. ROLE OF COMPANIONS 
 
Using the same observational data it has been written another article to explore the role 
of companions in the consultation. 
 
 
 
 
3.1 Introduction 
 
Companions often accompany patients to cancer consultations and participate at the 
encounter. They provide emotional, informational and logistical support for patients and 
may also participate at decisions regarding treatment (Laidsaar-Powell et al., 2013; 
Street and Gordon, 2008). During the consultation companions may contribute 
significantly in sustaining information needs by helping the patient to ask questions and 
express concerns (Ishikawa et al., 2005; Clayman et al., 2005). In this way companions 
can act as a conduit for information, but they may also elicit information from clinicians 
so that patients may be more informed (Hubbard et al., 2010). 
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In Italy, the assessment of family members’ participation, as well as patients’ 
participation, is a matter of recent interest and exploration that still remains to be further 
investigated. Recently some surveys on Italian patients’ informative needs have been 
published (Tamburini et al., 2000; De Lorenzo et al., 2004; Travado et al.,2005; 
Giacalone et al., 2005; Piredda et al., 2008; Annunziata et al., 2009) but very little is 
known on the characteristics of patients and companions and their contribution to 
question asking in cancer consultations. No study has been published on data obtained 
directly from audio recordings. 
Regarding the presence of a companion in the consultation, using the 
observational data the aim was to see if there are differences between Italian patients 
with, and without, attending companion in terms of socio-demographic and 
psychological characteristics, shared decision making preferences, decisional 
confidence, information requests, perception of shared decision making and satisfaction 
with decisions.  
Another aim was to see also if there are differences between patients with, and 
without, attending companion in terms of frequencies and topics of question asked, 
perceived shared decision making and satisfaction with decisions. And finally, which is 
the role played by the companion with question asking during the consultation.  
 
 
3.2 Methods 
 
Questions asked by companions, after being numbered and defined by their content 
according to the five categories (symptoms, etiology, prognosis, prevention and 
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treatment) suggested by Butow et al. (1994) and Clayton et al. (2003), were then 
classified also in terms of three possible functions: 1. to repeat or verify something 
already said by the oncologist, 2. to introduce new information requests (by changing 
topic) or 3. to help completing the collection of information (sharing questions on the 
same topic or issue already introduced by the patient). 
After listening to each audio-tape the role of each companion was described 
adopting the three categories suggested by Street and Gordon (2008): observer 
(contributed to the consultation less actively than the patient and showed a more passive 
role), partner (adopted a shared role), advocate (contributed actively to the consultation, 
stimulating also the patient to ask questions). 
 
 
3.3 Results 
 
Forty eight out of 70 patients (69%) attended with one or two (N = 1) relatives, who 
joined the consultation. Close family members prevailed (82%). The most frequent 
relationship was patient-husband/partner (48%), followed by the vertical relationship 
mother-adult child (23%). About half of the companion sample was gainfully employed 
and reported high school or University educational level (see Table 1) 
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Table 1. Characteristics of companions 
Relatives(N = 48)   
    N     (%) 
Male  28 (58.3) 
Degree of relationship   
Husband  22 (47.8) 
Son    3   (6.2) 
Daughter    8 (16.7) 
Sister    5 (10.4) 
Mother    1   (2.1) 
Friend    4   (8.3) 
Other    5 (10.4) 
Occupation   
Employed  24 (51.1) 
Student    1   (2.1) 
Housewife    7 (14.9) 
Retired  15 (31.9) 
Missing    1   (2.1) 
Education   
Primary school    7 (14.9) 
Junior high school  13 (27.7) 
High school  15 (31.9) 
University degree  12 (25.5) 
Missing    1   (2.1) 
 
 
 
There was a trend for triadic consultations to be longer (35.98 ± 13 min) than 
consultations without attending companion (30.45 ± 10.6 min), resulting in a greater 
number of total questions per consultation (23.7, SD 15.4 (range 0-70) versus 18, SD 
9.4 (range 7-49), but the differences fell short of significance (t(68) = 1.75, p = .09 and 
t(62.1) = –1.9; p = .06 respectively). 
Regarding the differences between accompanied and unaccompanied patients, 
accompanied patients were more often not employed (unemployed, housewife or 
retired) (x
2
(1) = 6.5, p = .01) than unaccompanied patients. No other socio demographic 
differences emerged. The two patient groups were similar in state anxiety, emotional 
distress and depression (see Table 2). 
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Table 2. Comparative characteristics of patients with and without companion during the 
consultation. 
 Patients not  
accompanied 
(N = 22) 
Patients  
accompanied 
(N = 48) 
t-test/x
2
, 
p-value 
Marital status  N     (%)  N     (%)  
Single   5 (22.7)   3   (6.3) x
2
(3) = 6.63 
Married 13 (59.1) 31 (64.6) p = .09 
Widower   1   (4.6) 10 (20.8)  
Divorced   3 (13.6)   4   (8.3)  
Occupation    
Employed 14 (63.6) 15 (31.3) x
2
(3) = 7.01 
Unemployed   0     (.0)   1   (2.1) p = .07 
Housewife   4 (18.2) 12 (25)  
Retired   4 (18.2) 20 (41.7)  
Education    
Primary school   3 (13.6) 12 (26.1) x
2
(3) = 2.65 
Junior high school   3 (13.6) 10 (37) p = .45 
High school 11 (50) 17 (15.2)  
University degree   5 (22.7)   7 (15.2)  
 Mean (range) Mean (range)  
Age 55.0  (41–68) 58.0  (31–75) t(68) = –1.26  
p = .21 
STAI-X1 score 42.4  (35–49) 43.8  (32–62) t(68) = –1.15  
p = .26 
GHQ-12 score   4.7  (3.3–6.1)   4.6 (3.7–5.5) t(50.4) = .26  
p = .80 
PHQ-9 score   6.1  (4.1–7.9)   6.0 (4.4–7.5) t(49.7) = .04  
p = .97 
Decision Self Efficacy Scale 33.9  (30.9–36.9) 34.5 (32.4–36.5) t(42.4) = –.35 
p = .74 
Control Preference Scale   N    (%)   N    (%)  
Active   3 (18.8)   1   (2.6) x
2
(2) = 5.8 
Shared 10 (62.5) 21 (55.3) p = .06 
Passive   3 (18.8) 16 (42.1)  
 
 
Patients with a companion showed, from the CPS measure, a tendency to prefer a 
passive role in the decision making process than those coming alone. 
As shown in Table 3, the number of questions was similar in both groups of 
patients as well as the distribution over the six content categories. Most of the questions 
focused on illness management (44%) and administrative procedures (37%). 
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Concerning the frequencies and topics of questions, companions asked significantly less 
questions per consultation than their kin patient (t(116) = 6.34; p < .01), but gave priority 
to the same topics. 
 
 
Table 3. Frequency of questions asked by patients, accompanied or not, and by 
companions 
 
Type of question 
Unaccompanied 
patients (N = 22) 
Accompanied 
patient (N = 48) 
Companions 
(N = 48) 
 
Mean (SD) [range  
per interview] 
Mean (SD) [range  
per interview] 
Mean (SD) [range  
per interview] 
Illness management 8.2 (6.6) [0–33] 7.4 (6.6) [0–27] 2.7 (3.5) [0–19] 
Administrative 6.1 (3.9) [0–19] 6.0 (4.2) [0–16] 2.4 (2.8) [0–10] 
Symptoms 1.9 (2.2) [0–8] 2.3 (2.4) [0–8]   .6 (1.7) [0–10] 
Life style / Prevention   .8 (1.5) [0–5]   .9 (1.5) [0–8]   .2   (.8) [0–5] 
Prognosis   .7   (.8) [0–2]   .7 (1.1) [0–6]   .3   (.7) [0–4] 
Etiology   .3   (.8) [0–3]   .3   (.7) [0–3]   .1   (.2) [0–1] 
Total 18  (9.4) [7–49] 17.5 (11.8) [0–48] 6.2 (6.9) [0–31] 
 
 
Regarding the role played by the companion on question asking during the consultation, 
most of the questions asked by the companions introduced requests for new information 
(53% of times) or helped to complete the obtained information (38%). Checking the 
information provided by the oncologist war relatively rare (9%). In terms of role, 67% 
of companions adopted a shared role, only 12% had a passive role and the remaining 
21% were active advocates.  
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3.4 Considerations 
 
Both accompanied and unaccompanied patients showed a high level of psychological 
distress, suggesting that the emotional condition did not increase the probability of 
support by a companion. 
Accompanied and unaccompanied patients asked on average the same number of 
questions. A similar finding was reported by Wolff and Roter (2011) who in their 
review on family presence in routine medical visits showed that “verbal contribution to 
medical dialogue was comparable when accompanied patients and their family 
companion were compared with unaccompanied patients”. 
Also the topics covered during the consultation were the same, with a preference 
to illness management issues and administrative procedures. This is not surprising, since 
the main focus in cancer consultations just after surgery is the discussion of treatment 
options. The large number of administrative questions burdened the oncologists, with a 
waste of precious consultation time, which, to our knowledge, has no previous mention 
in the literature. One possible reason could have been a lack of printed procedural 
information by which to predict such needs in a more appropriate manner. 
Companions asked fewer questions than their kin patient, as observed before for 
companions of lung cancer patients (Street and Gordon, 2008).  
They sought essentially the same type of information from the oncologist as the 
patients: primarily about treatment options and then about practical aspects of treatment. 
This finding parallels that of previous studies on information needs of informal 
caregivers, which showed that caregivers had a similar profile of information needs to 
those identified by women with breast cancer (Beaver and Witham, 2007; Luker et al., 
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1995, 1996). The presence of a companion increased, even if not significantly, the total 
number of questions per consultations, without suppressing question asking of the 
patients. Indeed companions showed to be active by asking questions on new topics, but 
at the same time the majority shared the information with the kin patient by helping her 
to complete the set of information given by the oncologist. This contributed to slightly 
prolong the consultation by about five minutes. Other studies have shown previously 
that the doctor spends more time and provides more information when the companion is 
present (Wolff and Roter, 2011; Eggly et al., 2011; Labrecque et al., 1991). 
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4. EXPERIMENTAL PHASE 
 
 
4.1 Aims 
 
The main aim pursued by this study is to assess if a pre-consultation heavily structured 
intervention, “Question Prompt-Sheet” (QPS) facilitates greater participation of patients 
(and accompanying key persons when present) in the consultation process, by 
determining an increase in questioning and/or in the number of different illness related 
issues (e.g. diagnosis, treatment, prognosis) being discussed with the oncologist; 
compared to a  more simple intervention. 
The study pursues other secondary aims as to assess the effect of the QPS on the 
level of patient involvement by the oncologists, on patient satisfaction and coping, on 
the oncologist’s perception of patient’s preferred decisional role and to explore the role 
of key persons accompanying the patient. 
In detail the study investigates if the intervention, determines as secondary aim: 
– a greater number of personal information needs expressed during the consultation 
(information needs expressed before the consultation correspond to those expressed 
during the consultation); 
– the perception of a greater capacity to cope with illness and a greater satisfaction 
with decisions made during the consultation; 
– greater patient generated and/or doctor generated involvement of the patient; 
– a better understanding of the received information and greater satisfaction; 
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– a different perception by the oncologist of patient’s preference regarding her 
participation in therapeutic decisions;  
– a different perception by the oncologist and by the patient of the doctor-patient 
relationship  
– a more patient-centered approach during the consultation 
 
 
4.2 Methods 
 
4.2.1 Design  
 
As a multicenter, randomized controlled trial, patients are attributed randomly to one of 
the two intervention groups on a 1:1 basis. The randomization sequence is being 
conducted off-site using the “random allocation of treatments balanced in blocks 
(ralloc)” package for Stata (Ryan, 2008)  and is stratified by center with a 1:1 allocation 
ratio of treatment. Block randomization (size 4) is used to minimize large imbalances 
between the intervention groups. The allocation sequences are generated by an 
independent individual, are stored in computer files and remain unknown to the 
researchers until the patient is randomized. 
Patients in group 1 are given the QPS, a list of 50 specific questions that have 
been chosen and adapted on the basis of previous studies in the field (Baile et al. 2000; 
Brown et al. 1999, 2001; Bruera et al. 2003; Clayton et al. 2003, 2007; Glynne-Jones et 
al. 2006; Ohlen et al. 2006), and are invited to select among the 50 possible questions 
37 
 
those, if any, they would like to ask to the oncologist. On the contrary those in group 2 
are given a control sheet on which writing the questions they would like to ask.  
Both randomization procedure and treatment allocation have been developed to 
fully conceal treatment allocation (Moher et al. 2010; Altman et al. 2001). Patients and 
oncologists are unaware of the allocation. The raters who analyze the audio-recordings 
are also blinded to the allocation of patients. 
The oncologists perform their consultation as usual, according to the clinical 
practice of their center. After concluding the consultation, they complete two 
questionnaires regarding the patient and the consultation.  
Standardized questionnaires are administered before the randomization and 
immediately after the consultation. 
 
 
4.2.2 Setting 
 
The participants are medical oncologists and patients newly diagnosed with early stage 
breast cancer who attending an outpatient oncology clinic for the first time. This study 
was conducted in three outpatient oncology clinics in Northern Italy run by the Hospital 
Trusts of Verona and Brescia. Visits for breast cancer patients were scheduled on fixed 
weekdays, from four to eight patients a day. Generally, in the first visit with the 
oncologist the aim is to communicate the histological results and to decide further 
medical treatments. 
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4.2.3 Sample and recruitment 
 
Oncologists 
 
Eligible oncologists include medical oncologists working in one of the three Oncology 
Departments and who were involved in the treatment of women with early stage breast 
cancer. 
 
Patients 
 
Patients are included if they are between the ages of 18 to 75 years, are recently 
diagnosed with early stage breast cancer and have adequate native language skills to 
complete questionnaires. The exclusion criteria consist in absence of metastasis or 
relapse and no mental deteriorations. 
 
 
4.2.4 Procedure  
 
At study commencement oncologists provide demographic data, including their gender, 
age, and years of oncology experience, and the DP questionnaire to measure their 
communication style. Consecutive patients at each site were screened for eligibility and 
informed of the purpose and requirements of the study by the study Research Assistant 
(RA). Prior to their initial consultation, all willing patients and family members provide 
written informed consent to participate and for the consultation to be audio recorded.  
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Immediately Pre-consultation 
 
Once recruited, participants an companions completed a brief questionnaire that 
collected socio-demographic data and a package containing six questionnaires. 
Patients were then randomized in one of the two intervention groups, using a 
randomization schedule developed by the study statistician. Patients were randomized 
within each center and recruitment continued until an approximately equal number 
of patients was recruited at each center to satisfy the sample size calculation. 
 Group 1 - participants were provided with a Question Prompt Sheet that 
commenced with a brief introduction explaining the importance of question asking. This 
was followed with a structured list of 50 evidence-based questions that patients 
commonly want to ask their oncologist during their first treatment discussion. 
Participants read through the questions and were asked to circle salient questions, if any, 
they would like to ask their oncologist.  
 Group 2 - participants were provided with a blank, lined paper form that 
commenced with an introduction explaining the importance of asking questions during 
their consultation. Participants were then asked to self-generate a list of questions they 
would like to ask their oncologist. Participants were instructed to: “Please indicate the 
issues which you want to discuss today with your oncologist”.  
Both forms were collected after they were completed for later analysis. Patients 
and companions did not take either the QPS or the self-generated list into the 
consultation. This decision was made in order to keep oncologists blind to which 
intervention patients had completed. The oncologists performed their visits according to 
the standard of usual clinical care at their center. All consultations were audio recorded 
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to allow an analysis of; a) the duration of the consultation and b) patient question 
asking. 
 
Immediately Post-consultation 
 
Immediately following the consultation, oncologists completed a questionnaire asking 
for the patient’s clinical information.  
They also complete a questionnaire measuring the perception of the patient as difficult.  
Patients and companions completed then six other questionnaires.  
 
The audio tapes and oncologist’ forms are collected and the audio tapes are examined 
for the content and number of questions asked by patients and companions, and are 
rated applying the OPTION scale (Elwyn et al., 2005; Goss et al., 2007a, 2007b) and 
the VR-COPE (Del Piccolo et al., 2008) (Table 4) 
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Table 4. Study instruments 
Scale Evaluation Explored area N items Time 
STAI-X1 
Patient and 
companion 
State anxiety level 20 
Before the 
consultation 
PHQ-9 
Patient and 
companion 
Depression 9 Before 
GHQ-12 
Patient and 
companion 
Psychological 
distress 
12 Before 
DSES* 
Patient and 
companion 
Confidence with 
decision 
11 Before 
CPS 
Patient, companion 
and oncologists 
Role in the decision 
making process 
vignettes Before 
EPQ-R 
Patient and 
companion 
Personality traits 24 Before 
DP Oncologists  
Oncologists’ 
communication 
style 
48 One time only 
PEI 
Patient and 
companion 
Ability to cope with 
illness 
6 
After the 
consultation 
SDMQ* 
Patient and 
companion 
Patient involvement 9 After 
SWD* 
Patient and 
companion 
Satisfaction with 
decision 
6 After 
PDRQ-9* 
Patient and 
companion 
Doctor-Patient 
relationship  
9 After 
RECALL* 
Patient and 
companion 
Recalling and 
understanding of 
information 
10 After 
STAI-X1/R 
Patient and 
companion 
State anxiety level 10 After 
DDPRQ-10 Oncologists 
Difficulties in 
relationship with 
the patient 
12 After 
Audio-
recording 
Consultation 
Interaction between 
doctor and patient 
- - 
OPTION External rater Involvement level  12 - 
VR-COPE External rater 
Aspects of patient-
centered 
communication 
9 - 
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4.2.5 Study measures 
 
 
4.2.5.1 Socio demographic and clinical data 
 
Patients’ socio demographic data are: age, education, family status and employment 
status. They were reported by patients and companions during the baseline assessment. 
Oncologists’ socio demographic data are: age, gender and years of experience. 
Data for oncology resident (when present during the consultation) was also obtained.  
Clinical data are: cancer stage and type, duration of illness, who has informed 
patient on diagnosis and when, therapeutic options considered appropriate for this 
patient. All these information were reported on a form by the oncologist. 
 
 
4.2.5.2 Primary outcome measure 
 
The primary outcome measure is the number of patient’s questions during the 
consultation since question asking is considered an index of the patient’s participation 
during the consultation. 
All audio recordings were transcribed. The audiotapes were analyzed for the 
length of the conversation and for the content and number of questions asked by 
patients. Questions were defined as “utterances in interrogative form that ask for 
information or clarification” (Street and Gordon, 2008). Three researchers were 
involved in the coding process. They identified the five main question categories 
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(symptoms, etiology, prognosis, prevention and illness management) starting from those 
described in the literature (Jenkins et al., 2001; Kaplan et al., 1996).A sixth category 
was added to account for administrative questions. 
The illness management category was split then into five other sub-categories: a) 
treatments specific for breast cancer, including administration, duration, frequency, 
effectiveness of the therapies (e.g. chemotherapy, hormone therapy, immunotherapy, 
surgery; b) side effects of treatment; c) check-ups and follow-up visits (e.g. 
mammography, blood tests); d) other pharmacological treatments related to pathologies 
in co-morbidity; and e) others not specified elsewhere. 
Questions were then coded accordingly to the categories previously identified.  
 
 
4.2.5.3 Secondary outcome measures 
 
Unmet information needs 
 
The number of unmet information needs that emerge during the consultation will be 
obtained by comparing the number of questions indicated by patients and their 
companion before the consultation (i.e., those selected in the QPS by patient) with those 
actually raised during the consultation (i.e., those identified subsequent to listening to 
the audio-recordings). 
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Ability to cope with illness 
 
It was measured with the Patient Enablement Instrument (PEI) (Howie et al. 1998). This 
questionnaire is a self-administered questionnaire of six items on a Likert scale from 0 
(same or less) to two (much better, much more).  
 
Patient involvement 
 
It was measured with the Shared Decision Making Questionnaire (SDM-Q) (Simon et 
al., 2006; Kriston et al., 2010) and the OPTION Scale (Elwyn et al., 2005; Goss et al., 
2007a, 2007b). The Shared Decision Making Questionnaire is a self-administered 
questionnaire of nine items on a Likert scale from 1 (completely disagree) to 6 (agree 
completely) that assesses patients’ perception of the decisional process and their level of 
involvement during the consultation, the information received on therapeutic options, 
potential risks and benefits regarding the participation at the decisional process. The 
OPTION Scale is composed of 12 items of operational definitions of different patient-
involving skills, rated on a Likert scale from 0 (behavior absent) to 4 (behavior 
observed at an excellent skill level). 
 
Satisfaction with decision 
 
It was measured with the Satisfaction with Decision Scale (SWD) (Holmes-Rovner et 
al. 1996). This is a self-report questionnaire of six items on a Likert scale from 0 
(completely disagree) to 5 (agree completely). Total score from 6 to 30. 
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Recall of information 
 
It was measured with the Recall Questionnaire (Brown et al., 2001; Gattellari et al., 
2002; Whelan et al., 1999). This questionnaire consists of six items that ask the patient 
to recall the received information on treatment decisions and pathology (e.g. ‘What was 
the treatment decision? Which treatment options were discussed?’). The questions have 
been prepared for the present study with reference to previous studies. The 
questionnaire enables an evaluation of the accuracy of patient’s recall and 
understanding of information delivered during the consultation by comparing the 
patients’ answers with the contents of the actual consultation discussion gathered from 
the consultation audio recording. 
 
Consultation atmosphere 
 
It was measured with VR-COPE (Del Piccolo et al., 2008). The VR-COPE assesses the 
content, the process and relational aspects of patient-centered communication during 
medical consultations on the basis of a multidimensional evaluation and comprises nine 
items. Each item is defined by operational definitions and rated on a 0 - 10 point scale. 
The scale is applied by trained raters to the consultation audio recordings. We expect 
that patients of the intervention group establish a better relationship with their 
oncologist and show higher scores in patient-centered communication. 
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Doctor-Patient relationship 
 
It was measured with the Patient–Doctor Relationship Questionnaire (PDRQ-9) (Van 
der Feltz-Cornelis et al., 2004) and the Difficult Doctor Patient Relationship 
Questionnaire (DDPRQ-10) (Hahn et al., 1994, 1996). The PDRQ-9 contains nine items 
on a Likert scale with anchors at 1 (not at all appropriate) to 5 (totally appropriate). The 
scale measures patient perceptions of their relationship with the doctor. DDPRQ-10 
contains 10 items on a Likert scale anchors at 1 (not at all) to 6 (a great deal) and is 
completed by physicians after the encounter with a patient. The questionnaire identifies 
the patients experienced as difficult patients. 
 
Perceived patient's preferred role 
 
It was measured with the Control Preference Scale (CPS, Oncologist version) (Degner 
et al., 1997; Giordano et al., 2008). This scale assesses how the oncologist perceives the 
role that patient might prefer regarding the decision making process. 
 
 
4.2.5.4 Process related and potential confounding variables 
 
The measures below have been collected in order to check their possible influence on 
question asking. 
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Consultation length and presence of companions 
 
The consultation length was measured in minutes and presence of at least one 
companion during the consultation was checked.  
 
Anxiety 
 
It was measured with the State Trait Anxiety Inventory (STAI-X1, XR) (Spielberger, 
1972; Spielberger et al., 1983; Lazzari, 1980). 
The State-Trait Anxiety Inventory X1 is a self-questionnaire completed by patients that 
measures the state anxiety in the situation contingent and transitory, or when the patient 
is preparing to visit. It differs from the anxiety trait which is instead a stable trait of the 
personality and provides a subjective assessment anxiety. The instrument is a validated, 
widely used measure that consists of  20 items with responses reported on a Likert scale 
with anchors at 1 (not at all) and 4 (very much) (Italian adaptation of Lazzari and 
Pancheri, 1980). There are items direct (that directly assess the presence of anxiety: 3, 4, 
6, 7, 9, 12, 13, 14, 17, 18) and indirect (that assess the absence of anxiety: 1, 2, 5, 8, 10, 
11, 15, 16, 19, 20).  
The total raw score is between 20 and 80 The cut-off for the high anxiety (which 
invalidates the test) is given by a value ≥ 95th percentile (raw score = 59-61). A score ≥ 
90th percentile (raw score = 52-58) is already indicative of a high level of anxiety. For 
the validity of the instrument is tolerated only one omission in the responses and in this 
case, the real score is estimated by multiplying by 9.10 the total score calculated on the 
remaining 9 items. Post Consultation Anxiety was measured using the 
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SpeilbergerSTAI-X1/R. This is a modified version of the STAI X1 and was developed 
specifically for the Cognitive Behavioral Assessment Program (CBA) (Sanavio et al., 
1986) The CBA is the initiative of a group of Italian Psychologists to produce a viable 
battery of tools for clinical assessment. The STAI-X1/R is a ten-item version of the 
STAI-XI with responses reported in an identical manner to the STAI-X1.  
 
Depression  
 
It was measured with the Patient Health Questionnaire depression scale (PHQ-9) 
(Kroenke et al., 2001, 2009; Thekkumpurath et al., 2011). It 'a self-questionnaire 
completed by the patient, which assesses the presence of depressive symptoms in the 
last two weeks. The symptoms reported are taken from the DSM-IV, the first two items 
relate to depressed mood and anhedonia (the cardinal symptoms of MDD), followed by 
7 additional items about alteration in sleep, low energy, appetite, feelings of guilt and 
failure, difficulty concentrating, hyper / hypokinesia thoughts and self-harm. It consists 
of 9 items each rated on a Likert scale from 0 (no symptom "never") to 3 (maximum 
distress caused by the symptom "almost every day"), with total scoring between 0 and 
27.  
The scoring can be evaluated as a continuous score or with an algorithm. It has 
become a screening tool for very popular to its brevity and simplicity. A score  ≥ 8 and 
a sensitivity rate of 93% while maintaining adequate specificity of '81%. The standard 
psychometric screening for depression have not been defined; However, rates of 
sensitivity '85% and specificity from 70% to 75% are usually considered acceptable 
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parameters and the PHQ meet these standards when used as a measure of continuity to 
cut-off ≥ 8.  
Yet the literature does not provide us with suggestions for the statistical 
treatment of the items are missing, so we decide to handle them as follows: a) with a 
total score > 8 and only one missing data in the presence of the remaining valid 
responses, it will calculate the average of the values valid; b) with a total score < 8 and 
valid questions > 7 will calculate the average of the valid values; c) with a total score < 
8 and valid questions < 7 the final score will not be calculated and the questionnaire will 
be considered lost. 
 
General wellbeing 
 
It was measured with the General Health Questionnaire (GHQ-12) (Politi et al., 1994), a 
self-questionnaire completed by the patient that allows to evaluate the psychological 
well-being of the patient and to identify the presence of a possible emotional distress It 
was developed by Sir D. Goldberg in the seventies and used in various settings. It 
consists of 12 items each rated on a Likert scale from 1 (no symptom) to 4 (maximum 
distress caused by the symptom) used to calculate a total score between 0 and 12. The 
subjects with a score equal to or more than 4 have a probability higher than 80% have 
psychiatric disorders, such as anxiety and depression. Goldberg argues that with a score 
> 4 the likelihood of having mental disorders Is > 80%. For this study we chose to 
follow the dichotomous criterion for scores to individual items (0-0-1-1) already 
adopted previously in an Italian context. For the total score is calculated by adding the 
scores dichotomous; the cut-off for the presence of an emotional discomfort is given by 
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a score tot ≥ 3 In the literature there is no suggestion regarding the statistical 
management of the missing item for which it was decided to handle them in the 
following way: a) in If the total score ≥ 3 with only one missing data and the remaining 
valid responses, it will calculate the average of the valid values; b) in the case of total 
score ≤ 3 and valid questions > 9, we calculate the mean of valid values; c) in the event 
of a total score < 3 and valid questions < 9 the final score will not be calculated and the 
questionnaire will be considered lost. 
 
Personality traits 
 
They were measured with the Eysenck Personality Questionnaire (EPQR-S) (Eysenck et 
al., 1985). Eysenck initially conceptualized personality as two, biologically-based 
independent dimensions of temperament measured on a continuum: 
Extraversion/Introversion (E): Extraversion is characterized by being 
outgoing, talkative, high on positive affect (feeling good), and in need of external 
stimulation. According to Eysenck's arousal theory of extraversion, there is an optimal 
level of cortical arousal, and performance deteriorates as one becomes more or less 
aroused than this optimal level. Arousal can be measured by skin conductance, brain 
waves or sweating. At very low and very high levels of arousal, performance is low, but 
at a better mid-level of arousal, performance is maximized. Extraverts, according to 
Eysenck's theory, are chronically under-aroused and bored and are therefore in need of 
external stimulation to bring them up to an optimal level of performance. About 16 
percent of the population tend to fall in this range. Introverts, on the other hand, (also 
about 16 percent of the population) are chronically over-aroused and jittery and are 
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therefore in need of peace and quiet to bring them up to an optimal level of 
performance. Most people (about 68 percent of the population) fall in the midrange of 
the extraversion/introversion continuum, an area referred to as ambiversion. 
Neuroticism/Stability (N): Neuroticism or emotionality is characterized by high 
levels of negative affect such as depression and anxiety. Neuroticism, according to 
Eysenck's theory, is based on activation thresholds in the sympathetic nervous system or 
visceral brain. This is the part of the brain that is responsible for the fight-or-flight 
response in the face of danger. Activation can be measured by heart rate, blood 
pressure, cold hands, sweating and muscular tension (especially in the forehead). 
Neurotic people — who have low activation thresholds, and unable to inhibit or control 
their emotional reactions, experience negative affect (fight-or-flight) in the face of very 
minor stressors — are easily nervous or upset. Emotionally stable people — who have 
high activation thresholds and good emotional control, experience negative affect only 
in the face of very major stressors — are calm and collected under pressure. 
For this study we decided to use only these two dimensions excluding the 
Psychoticism/Socialization (P) and the Lie (L) scales that constitute the full EPQ-R 
version with 48 items. So we have two axes with a total of 24 items.  
 
Confidence with decision 
 
It was measured with the Decision Self Efficacy Scale (DSES) (O’Connor, 2012). It is a 
self-questionnaire completed by the patient which allows the assessment of the degree 
of confidence that the patient has in itself with respect to its ability to make a decision 
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about their own health. It consists of 11 items, each of which is rated on a Likert scale 
from 0 (no security) to 4 (very safe), with total scoring between 0 and 44. 
 
Patient’s  preference role  
 
The role they want to have in the decision making process was measured with the 
Control Preference Scale (CPS) (Degner et al., 1997; Giordano et al., 2008). The 
Control Preferences Scale was developed to measure a construct that emerged from a 
grounded theory of how treatment decisions are made among people with life-
threatening illnesses. The control preferences construct is defined as "the degree of 
control an individual wants to assume when decisions are being made about medical 
treatment." The CPS consists of five cards that each portrays a different role in 
treatment decision-making using a statement and a cartoon. These roles range from the 
individual making the treatment decisions, through the individual making the decisions 
jointly with the physician, to the physician making the decisions.   
 
Patient-centered communication style  
 
It was measured with the Doctor-Patient (DP) Scale (De Monchy, 1988). 
It consists of a self-administered questionnaire where it should be indicated on a five-
point Likert scale (1 to 5, the score 3 is neutral), the agreement or disagreement relative 
to 48 statements regarding medicine general problem, and specifically, the doctor-
patient relationship. 
The maximum score is 240, the lowest 48. 
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The reference system is represented by a continuum with two poles regarding two 
different attitudes: 
a) the pole D (score 1) expresses a "centered doctor disease-oriented" position: 
the physician's role  is seen mainly in technical and scientific terms, the focus is more 
on the disease than on the patient, the doctor-patient aspects appear in the background. 
b) the pole P (score 5) expresses a "patient-centered problem-oriented" position: 
the physician's role is seen primarily in relational terms and the focus is more on the 
patient than on the disease, promoting a patient individual approach. 
 
 
4.2.6  Sample size calculation  
 
A sample of 300 patients will be recruited. This number has been estimated to account 
for approximately a 15% of withdrawal rate, so that 250-260 patients will complete the 
study, with about 130 patients in each arm. The primary outcome measure is the number 
of patient questions. The international literature reports a mean number of 9 questions 
(range 0-53) for breast cancer patients. Since such data are not available in the Italian 
context, an observational phase was conducted. We recruited a sample of 30 patients 
(10 for each center) with the same characteristics, in order to assess the number and type 
of questions asked by the patient during the consultation, to understand the ongoing 
interaction between oncologists and patients in a first encounter and to test the 
feasibility of procedures and questionnaires. This observational study resulted in a mean 
number of 18 (SD =13) patient questions asked during a first encounter with the 
oncologist. An intervention intended to increase the number of questions might be 
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considered efficacious with an increase of 30%. The sample size required to evidence 
such difference was calculated using the "sampsi" command of Stata 11 (Stata.Corp., 
2011), assuming a power of 80% and a two-sided significant level of 5% on a student t-
test for differences between independent groups (Pocock, 1983; Sullivan et al., 2003). 
 
 
4.2.7 Data Analysis 
 
Standard statistical techniques were used to describe characteristics of patients in both 
groups. The total number of questions asked and the number of questions asked within 
each arms were calculated. 
Comparisons between groups in the socio-demo characteristics were performed 
to check the randomization balancing, using chi-squared and t-test. 
In order to explore the presence of confounding effects on the outcome some 
preliminary analyses were performed using correlation measures. According to 
literature (Wilson et al., 1991; Wilson & Childs, 2002; Deveugele et al., 2002) we 
decided to consider mainly the consultation length as a confounding variable along with 
the presence of a family member. 
The primary outcome, number of questions patients asked, was compared 
between the two intervention groups using simple t-tests and also multilevel analyses to 
take into account the nested structure of data (Skrondal & Rabe-Hesketh, 2004). 
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4.3 Results  
 
Among all patients with breast cancer who attend the three oncology divisions during 
the recruitment phase, a total number of 537 were accessed for eligibility; respectively, 
188 in the first center (Borgo Trento), 152 in the second (Brescia) and 197 in the third 
(Borgo Roma). 143 (26.63%) were excluded according to our exclusion criteria: 96 
patients were excluded for age, 10 for language, 2 for the presence of metastases and 35 
for the presence of relapse. The exclusion rates are quite homogenous in the three 
centers: 31.91% (n = 60) in center 1, 26.4% (n = 52) in center 2 and 20.39% (n = 31) in 
center 3. 
Of 394 (73.37%) eligible patients that were recruited, 70 (17.77%) patients 
refused to participate in the study (also the rejection rates seems to be quite 
homogeneous: 18.75% (n = 24) in center 1, 14.05% (n = 17) in center 2 and 20% (n = 
29) in center 3; so that 324 (82.23%) patients were randomized. 164 patients were 
assigned to the QPS group while 160 were assigned to the QL group.  
We lost 16 (4.94%) audiotapes due to technical reasons: 6 in the QPS group and 
10 in the QL group, leaving 308 patients (158 for QPS and 160 for QL) available for the 
analysis (see flow diagram).  
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Flow diagram. 
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4.3.1 Socio-demographic data 
 
Most patients were married (69.8%) with an average age of 55.6 years, had a high 
school degree (40.5%) and were employed (56%).  
Most oncologists were female (85%) with an average age of 38.8 years and an average 
of 11.3 years as medical oncologists (Table 6). 
 
 
Table 6. Oncologists' Characteristics 
 
 
 
Comparisons of socio-demo characteristics between the two intervention arms shown 
no significant differences (see Table 7), so we can say that the randomization generated 
balanced groups. 
 
Oncologist Characteristics (N = 20) 
Center 1 Center 2 Center 3 
N SD N SD N SD 
Average Age 37.2 12.6 41.5 7.9 36.5 9.8 
Average Years as Oncologist 10.6 10.9 14.4 6.2 8.3 7.7 
Gender (n = female oncologist) 4  7  6  
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Table 7. Patients' characteristics 
 
Center 1 
(n = 100) 
Center 2 
(n = 101) 
Center 3 
(n = 107) 
Total 
(n = 308) 
Patient Characteristics* 
QPS 
(n = 53) 
QL 
(n = 47) 
QPS 
(n = 51) 
QL 
(n = 50) 
QPS 
(n = 54) 
QL 
(n = 53) 
QPS 
(n = 158) 
QL 
(n = 150) 
Chi
2
/t, 
p-value 
 N % N % N % N % N % N % % %  
Marital Status                
Single 8 15.1 5 10.6 8 16 4 8 4 7.5 5 9.6 12.8 9.4 
x
2
 = 2.42,  
p = 0.49 
Married 34 64.2 36 76.6 33 66 41 82 36 67.9 33 63.5 66 73.8 
Other (Divorced, Widowed) 11 20.7 6 12.8 9 18 5 10 13 24.5 14 26.9 21.2 16.8 
Education               
x
2
 = 1.42,  
p = 0.70 
Primary School 12 22.7 15 31.9 6 12.2 8 16 8 14.8 8 15.1 16.7 20.7 
Secondary School 13 24.5 14 29.8 20 40.8 12 24 14 25.9 13 24.5 30.1 26 
High School 20 37.7 17 36.2 17 34.8 26 52 25 46.4 19 35.8 39.7 41.3 
University 8 15.1 1 2.1 6 12.2 4 8 7 12.9 13 24.6 13.5 72 
Employment               
x
2
 = 0.02,  
p = 0.88 
Employed 30 56.6 30 63.8 26 52 28 56 30 55.5 28 52.8 54.8 57.3 
Unemployed 23 43.4 17 36.2 24 48 22 44 24 44.5 25 47.2 45.2 42.7 
Patient Age M, (SD) 57.2 (13,02) 52.3 (36.8) 57.2 (9.2) 57.1 (9.9) 54.5 (10.4) 55.6 (13.5) 54.9 (27) 57.2 (9.5) 
t = 0.99,  
p = 0.5 
* information is missing in some patients, here the percentage are obtained on valid cases. 
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4.3.2 Characteristics of the consultation and confounding variables 
 
Consultation length and presence of companions 
 
These consultation characteristics represent confounding effects, without interaction 
with the two intervention arms; therefore they were included into the regression model 
in order to better evidence the intervention effect. 
 
 
Graph 1. Consultation length distribution in the two groups. 
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The length of the consultations ranged between 12 and 129 minutes with a mean of 49 
minutes (SD = 19) (Graph 2). No statistically significant difference was found between 
the two groups (t = – .62; p = .53). 
 
 
Graph 2. Consultation length comparison in the two intervention groups 
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If we look inside the three centers (Graph 3) we can notice that in center number 3 the 
average length was slightly higher. 
 
 
 
Graph 3. Comparison of consultation length by groups and by center. 
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The correlation between the number of questions and the consultation length shows a 
moderate correlation not statistically significant (r = .45; p-value > .01), (Graph 4).  
 
Graph 4. Correlation between number of question and consultation length. 
 
 
A family member was present in 72% of consultations, without any difference in the 
two groups (Pearson chi-square (dof 1) =  .17, p-value = .68), (Table 8). 
 
 
Table 8. Presence of family members 
Presence of family member 
QPS QL Total 
N (%) N (%) N % 
Patients with family members 116 73 107 71 223 72 
Patients only 42 27 43 29 85 28 
Total 158  150  308  
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Correlation between the number of questions and the presence of family member was  
r = .24; p-value >.01. 
 
Personality traits  
 
Extroversion scale: the extroversion scale showed equal score between the two groups 
of intervention (Graph 5). As shown by the Kolmogorov-Smirnov statistic, there are no 
significant differences between the two groups (d = .05; p = .99). 
 
Graph 5. Extroversion score.  
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Neurotism scale: the neurotism scale showed equal score between the two groups of 
intervention (Graph 6). As shown by the Kolmogorov-Smirnov statistic, there are no 
significant differences between the two groups (d = .08; p = .06). 
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Graph 6. Neurotism score. 
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No significant correlation has been found between a high score on the extroversion  
scale  (r = .08; p = .15) or a low score on the neurotism scale (r = – .01; p = .95) and the 
number of questions asked by patients. The correlation was not significant even within 
the two groups. Respectively the correlation was r = .02; p = .81 (extroversion);r =  
– .03; p = .72 (neurotism) in the QPS group and r = .13; p = .11 (extroversion); r = .01; 
p = .87 (neurotism) in the QL group. 
 
 
Anxiety  
 
Most of the patients were not anxious (67%) and the anxiety levels were equal between 
the two groups (M = 2.39 and SD = .57 in QPS vs. 2.45 and .62 in QL; t(302) = .97 p = 
.33) prior to the consultation. According to this balanced result we have decided to 
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consider the anxiety state variation also as a secondary aim, comparing the two states, 
before (STAI-X1) and after (STAI-X1/R) the consultation. As shown in the two 
compared box-plots graphs (Graph 7), after the consultations anxiety decrease in similar 
way in both groups (mean = 1.94 and SD = .64 in QPS vs. 1.93 and .63 in QL t(251) = 
.07; p = .94). 
 
Graph 7. Anxiety comparison before and after the consultation within the two groups of 
intervention. 
STAI-X1 STAI-X1/R 
  
 
Concerning the depression, most of the patients were not depressed (68%). The 
difference between the two groups of intervention was not statistically significant even 
for depression (x
2 
= 2.40, p = 0.12). 
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average of 16 questions (SD = 12.4). The difference between pooled arms was 
statistically significant (t(271) = –1.99, p = .05).  
 
 
Graph 8. Question asked distribution 
 
 
 
The effect of hierarchical structure of our sample (patients are nested into doctor and 
doctor nested into centres) was measured by intra-class correlation (ICC, which 
measures the proportion of the total variability explained by the between-level 
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The results obtained by the mixed linear model, taking into account what 
mentioned above, show that the difference between interventions lost its significance (b 
= 1.7; 95% CI: –.29 - 3.64. p = 9%), while the confounding effects, due to consultation 
length (b = .29; 95% CI: .24 -.33. p < 1%) and presence of companion (b = 5.3; 95% CI: 
3.1 - 7.5 p < 1%) remain already significant (see Table 9). 
 
Table 9. Regression model and Intra-Class Correlation 
 
 
As illustrated by the Graph 9, there was a slight imbalance in the centers because of a  
higher average of question asked in center number 3 compared to the other, especially 
in the QL group. 
 
 
 
 
 
 
 
 
 
Variables β SE P-value 95% CI 
Groups: QPS vs. QL 1.68 1.00 .09 – .29 - 3.64 
Presence of companions 5.30 1.12 .00 3.10 - 7.50 
Length .29 .024 .00 .24 - .33 
ICC     
Center .079 - - - 
Doctor | Center .117 - - - 
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Graph 9. Question number comparison within centers and groups. 
 
 
 
Topics of patient questions 
 
Patient questions were coded by researchers into five main categories describing their 
contents. They are prevalently addressed to illness management (41.2%) and 
administrative (32.5%), followed by symptoms (13.9%), prevention (6.9%), prognosis 
(3.8%) and etiology (1.6%). 
Regarding the illness management subcategories, the most frequent questions asked by 
patients were related to chemotherapy and hormone therapy, in order to better know 
what they are and how they work.  (see Table 10).  
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Table 10. Mean of question regarding the illness management category in the two groups. 
Illness management 
QPS QL TOTAL 
Mean SD Mean SD Mean SD 
Treatment       
Chemotherapy 1.30 2.62 .94 1.73 1.12 2.23 
Hormone Therapy 1.09 1.57 1.3 1.85 1.22 1.71 
Radiotherapy .74 1.19 .76 1.30 .75 1.24 
Immunotherapy .14 .73 .08 .54 .11 .64 
Surgery* .54 1.28 .57 1.51 .55 1.40 
Other .16 .49 .14 .47 .15 .48 
Side Effects       
Chemotherapy .75 1.65 .62 1.22 .69 1.45 
Hormone Therapy .54 1.00 .90 1.50 .72 1.28 
Radiotherapy .20 .50 .18 .63 .19 .57 
Immunotherapy .02 .18 .01 .08 .01 .14 
Surgery* .04 .19 .14 .38 .09 .31 
Other .01 .08 .01 .08 .01 .08 
Check-Up** .30 .62 .47 1.05 .38 .86 
Other Treatment*** .17 .49 .27 1.19 .22 .90 
Other .01 .08 .01 .12 .01 .10 
* Both before and after the consultation 
** Mammography, echography, blood test etc. 
*** Diseases in co-morbidity 
 
 
4.3.4 Secondary Outcomes 
 
Concerning the secondary outcomes, it has been adopted the Kolmogorov-Smirnov test 
for equality of distribution functions to describe the score differences of the 
questionnaires administered after the consultation in the two groups of interventions. 
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Shared Decision-Making 
 
The SDMQ showed equal score between the two groups of intervention. As shown by 
the Kolmogorov-Smirnov there are no significant differences (d = .08; p = .86), (Graph 
10). 
 
 
Graph 10. SDMQ score within the two groups.  
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Patient Enablement 
 
The Patient Enablement Instrument (PEI) showed equal score between the two groups 
of intervention. As shown by the Kolmogorov-Smirnov test for equality of distribution 
functions, there are no significant differences (d = .05; p = .99), (Graph 11). 
 
 
Graph 11. PEI score within the two groups. 
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Patient-Doctor relationship 
 
The Patient-Doctor Relationship Questionnaire (PDRQ-9) showed equal score between 
the two groups of intervention. As shown by the Kolmogorov-Smirnov test for equality 
of distribution functions, there are no significant differences (d = .16; p = .08) (Graph 
12). 
 
Graph 12. PDRQ-9 score within the two groups. 
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Satisfaction with decision 
 
Patients showed high levels of satisfaction in both groups (87.5% of patients with a total 
score higher than 23). As shown by the Kolmogorov-Smirnov test for equality of 
distribution functions, there are no significant differences (d = .11; p = .38) (Graph 13). 
 
 
 
Graph 13. SWD score within the two groups. 
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4.4 Discussion 
 
 
Patients asked a mean of 13 questions in the QPS group and 16 in the QL, confirming 
previous findings, which showed that cancer patient have many information needs 
(Jenkins et al., 2001; de Bock et al., 2004). Their information needs were comparable to 
those reported in the same context in other countries (Siminoff et al., 2000; Butow et 
al., 2004; Eggly et al., 2011; Clayton et al., 2003; 2007), although Italian patients asked 
slightly more questions (13-16 in our study vs. 9-13). 
We had hypothesized that QPS delivered before the first oncologic consultation 
would result in patient asking more questions compared to a sample open-ended 
question (QL) about question patients wish to ask. No overall increase in question 
asking was observed in patients receiving a QPS. 
We can hypothesize different explanations for our findings. 
In our study we compared QPS to an open-ended question (QL) in the other 
group which can have played an important role as well as the QPS in preparing the 
patients prior the consultation to focus better their attentions to what they wish to ask 
their oncologist. Even if we have found that, according to the mixed linear model, the 
difference between interventions has lost its significance, maybe patients in the QL 
group ask slightly more questions because of the close and personal nature of those 
questions. They have the possibility to reflect on their own questions instead of decide, 
from a standardized list, those they want to ask. And this can lead to a better recall 
ability of their questions during the consultation. 
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We observed no difference between the two groups in the duration of the consultation 
with a mean duration of 49 minutes (SD = 19.0). These findings are slightly more 
compared to other studies (Brown et al., 2001; Butow et al., 2002; Clayton et al., 2007). 
The overall length of the consultation remained unchanged but the time within the 
consultation might be spent differently. How the oncologist and patient use the time 
may be as important as the amount of time itself (Wilson et al., 2002). Since the number 
of questions are quite similar to other studies maybe the Italian oncologists spend more 
time giving information and explaining carefully all the results. 
 
 
4.4.1 Strength, limitations and applicability of findings 
 
This study explores the effect of QPS delivered before an initial breast cancer 
consultation in Italy. The sample was large enough to generalise our results to all the 
patients with the same characteristic (Italian-speaking, female, aged 18-75, breast 
cancer at an initial stage) referring to the three centres (population in the catching areas 
about 2.157.305).  Results can be extended also to female breast cancer patients in the 
north of Italy, as services organization and culture are similar; there are doubts about 
generalizability over all Italy. Results may not be generalizable to other cultural groups, 
other oncological setting or patients with different stage, therefore replication is 
recommended.   
It has been demonstrated in English speaking countries that a QPS is a useful 
tool to improve patient’s participation during the consultation. However, we contend 
that consultation communication may vary across cultures and thus there is a need to 
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explore the efficacy of a QPS in Non English speaking countries to explore cross 
cultural differences.   
To our knowledge there are no published randomized controlled trials in Europe 
that assess the effects of a pre-consultation QPS on patient and companion 
communication. Our study has a strong design that incorporates computerised random 
allocation, blinding of data-collection staff and the use of audio-recordings as an 
objective measure of consultation communication. The analysis of the consultation 
recordings is a valuable research method and is a recommended tool for documenting 
the interaction between patients and oncologists (Tattersall, 2002).  
There are some limitations to consider. The QPS in this study was administered 
before the consultation and collected by the researcher and not available to the patient 
during the consultation.Thus patients may not remember their questions selected on the 
QPS and undermine the hypothesis of the greater participation of the QPS intervention 
group. Moreover some authors (Clyton et al., 2007, Brown et al., 2001)  observe that 
without physician endorsement, the QPS had a limited impact on patient questions. We 
selected this study method to ensure that participating oncologists were, a) kept blind to 
the intervention or control status of the patients and b) not forced to change their routine 
clinical practice.   
 
 
4.4.2 Clinical implication 
 
The majority of cancer patients in western world now desire full information about their 
disease, although in all reported studies, there is a small but significant proportion of 
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patients who prefer minimal information and/or a passive role in decisions about their 
care (Cassilieth et al., 1980; Degner et al., 1997). Inviting patients to prepare for their 
consultation (with QPS or just thinking to questions they wish to ask) can be useful to 
improve patient participation and collaboration and can assist in organising the 
consultation more efficiently. The opportunity to rehearse their information needs 
before the consultation can help patients to better focus on them and to use the 
consultation more efficiently. Preparing for the consultation can modify the process of 
information exchange, increase patients participation with greater number of satisfied 
needs, improve satisfaction with the consultation, with potential benefits for treatment 
adherence and consequently treatment efficacy. Because of the complexity of the 
interaction between the patient and the oncologist, nevertheless focusing on the patient 
alone may not produce short and long term benefits for patients. It is plausible that 
oncologists trained specifically to respond to more active patients can further enhance 
patient involvement and lead to a more successful consultation. Therefore, changing 
behaviour of both parties (oncologist and patient) toward the ideal shared decision-
making model seems to be the most desirable and the probably most effective 
intervention. The goal would be to change the overall culture of the consultation, with 
empowered patients encouraged routinely to identify questions for their oncologists and 
oncologists effectively trained to identify and adapts to the needs of their patients and to 
endorse active patients, as part of usual care. 
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4.4.3 Future directions 
 
Question asking is one indicator of patient involvement in consultations, but what is the 
desirable number of questions to ask during the usual 20-30 minute consultation? How 
much information can the patient understand and recall correctly? Moreover, does the 
great number of patients’ questions really represent their information needs, or does it 
reflect the difficulties of oncologists in providing clear information? We want patients 
to be more aware of their needs, asking more precise questions to their doctors on one 
hand, and on the other, to have more skilled doctors to answer those questions. All these 
are challenging tasks and exploring this aspect would be a worthwhile addition to future 
research and clinical training.  
The impact of an intervention to prepare patients for the consultation used 
routinely and over time, in terms of cost/effectiveness, needs also to be examined. It is 
plausible that these preparation interventions may have broad application for facilitating 
patient and oncologist communication. 
Even if we did not found variables associated to question asking, some patients 
might find the interventions more helpful than others. Further research is needed to 
identify those patients to whom intervention are likely to be most beneficial. 
Finally, increased knowledge of cultural influences on question asking and on 
doctor-patient communication may contribute to improved mutual understanding 
between countries. In Europe the advantages of much more mutual understanding may 
be at medical encounter level with a more fruitful doctor-patient interaction and, at 
macro-level, with more effective co-operation and integration of European health care 
policies. 
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4.5 Conclusion 
 
Patients’ involvement and participation in therapeutic programs is of great interest not 
only to physicians but to all health professionals engaged in improving patients’ 
adherence to treatment regimens or operating in the field of health promotion. 
Preparing for the consultation (using QPS or a QL as well) is a quick and simple 
way of prompting the patients to ask questions and may improve the overall 
communication between oncologist and patient. Patients can prepare themselves as best 
they can for the consultation to get the very best out of it. These interventions will be 
easy to disseminate and to be used in routine clinical practice to increase patient 
participation. Patients often wait for some time in the waiting room before the visits, 
and QPS or other preparing sheets, can be used constructively in this time. Adding to 
this intervention on patient a specific training for oncologist in order to better endorse 
more active patients in the consultation may allow such interventions to have their full 
impact on greater patient involvement in decision making processes.  
Findings from the present study provided a basis for further research in the field 
and provide potentially important results for clinicians, patients and policy makers that 
may lead to a wider use of tools that can help patients to focus on their information need 
prior the consultation. 
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LA PARTECIPAZIONE AL PROCESSO INFORMATIVO-DECISIONALE DELLA PAZIENTE 
AFFETTA DA NEOPLASIA MAMMARIA. UNO STUDIO CLINICO MULTICENTRICO 
 
Informazioni per la paziente  
 
Gentile Signora 
Le proponiamo di collaborare ad uno studio sperimentale che ha l’obiettivo di osservare il livello di 
coinvolgimento della paziente durante la visita medica ed il ruolo dei familiari nel processo 
informativo-decisionale.  
L’obiettivo finale è quello di poter migliorare la qualità delle cure prestate dal nostro Servizio di 
Oncologia e per dare una risposta sempre più adeguata alle esigenze dei pazienti ed eventualmente 
dei familiari che li accompagnano. 
 
Le chiediamo di acconsentire: 
a) alla raccolta di alcuni suoi dati personali; 
b) alla audio registrazione del colloquio odierno con l’oncologo;  
c) alla compilazione di 7 questionari prima della visita con l’oncologo (durata complessiva di circa 
15 minuti); 
d) alla compilazione di 6 questionari dopo la visita con l’oncologo (durata complessiva circa 15 
minuti) 
 
L’audio-registrazione è l’unico modo che ci consente di valutare come avviene lo scambio 
informativo durante il colloquio. 
Verrà garantito il massimo anonimato e il suo nome verrà sostituito con un numero per evitare 
qualunque possibile identificazione. Avranno accesso ai dati raccolti soltanto le figure professionali 
coinvolte nella ricerca e che sono comunque tenute a mantenere il segreto professionale. 
Tutte le informazioni connesse alla Sua partecipazione saranno trattate in modo strettamente 
riservato in conformità alle norme sul trattamento dei dati personali (decreto legislativo 196/2003). 
 
La partecipazione a questo studio è completamente volontaria. Lei è libero/a di non partecipare o di 
ritirarsi in qualsiasi momento (chiedendo di spegnere il registratore in qualsiasi momento del 
colloquio) senza per questo dover dare alcuna spiegazione; in ogni caso il nostro Servizio di 
Oncologia continuerà a garantirLe, con la dovuta attenzione, tutta l’assistenza sanitaria di cui ha 
bisogno. 
 
Firma del paziente per presa visione………………….………………………………………….. 
 
Nome in stampatello del ricercatore che ha informato la paziente…………………………… 
 
Firma del ricercatore che ha informato la paziente…………………………………………… 
 
Luogo……………………………………………………………..Data……………………………… 
 
[Se la paziente non è in grado di leggere o di firmare, un testimone indipendente dallo staff dello 
studio deve essere presente durante l'intera discussione relativa al consenso informato. Il testimone 
deve firmare e datare personalmente la dichiarazione di consenso informato dopo che il modulo 
stesso e qualsiasi altra informazione scritta siano stati letti e spiegati al soggetto e questi abbia 
espresso il consenso verbale alla partecipazione allo studio]. 
In questo caso: 
 
Nome in stampatello del testimone…………………………………. …………………………… 
 
Firma del testimone indipendente………………………………………………………………… 
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LA PARTECIPAZIONE AL PROCESSO INFORMATIVO-DECISIONALE DELLA PAZIENTE 
AFFETTA DA NEOPLASIA MAMMARIA. UNO STUDIO CLINICO MULTICENTRICO 
 
Informazioni per il familiare  
 
Gentile Signora/Signore 
Le proponiamo di collaborare ad uno studio sperimentale che ha l’obiettivo di osservare il livello di 
coinvolgimento della paziente durante la visita medica ed il ruolo dei familiari nel processo 
informativo-decisionale.  
L’obiettivo finale è quello di poter migliorare la qualità delle cure prestate dal nostro Servizio di 
Oncologia e per dare una risposta sempre più adeguata alle esigenze dei pazienti ed eventualmente 
dei familiari che li accompagnano. 
 
Le chiediamo di acconsentire: 
a) alla raccolta di alcuni suoi dati personali; 
b) alla audio registrazione del colloquio odierno con l’oncologo;  
c) alla compilazione di 7 questionari prima della visita con l’oncologo (durata complessiva di circa 
15 minuti); 
d) alla compilazione di 6 questionari dopo la visita con l’oncologo (durata complessiva circa 15 
minuti) 
 
L’audio-registrazione è l’unico modo che ci consente di valutare come avviene lo scambio 
informativo durante il colloquio.  
Verrà garantito il massimo anonimato e il suo nome verrà sostituito con un numero per evitare 
qualunque possibile identificazione. Avranno accesso ai dati raccolti soltanto figure professionali che 
sono tenute a mantenere il segreto professionale. 
Tutte le informazioni connesse alla Sua partecipazione saranno trattate in modo strettamente 
riservato in conformità alle norme sul trattamento dei dati personali (decreto legislativo 196/2003). 
La partecipazione a questo studio è completamente volontaria. Lei è libera di non partecipare o di 
ritirarsi in qualsiasi momento (chiedendo di spegnere il registratore, durante o alla fine del colloquio) 
senza per questo dover dare alcuna spiegazione; in ogni caso il nostro Servizio di Oncologia 
continuerà a garantire al Suo familiare, con la dovuta attenzione, tutta l’assistenza sanitaria di cui ha 
bisogno. 
 
Luogo……………………………………………..Data………………………………………….. 
 
 
Firma del familiare per presa visione………………….…………………………………….……….. 
 
Nome in stampatello del ricercatore che ha informato il familiare………………………………… 
 
Firma del ricercatore che ha informato il familiare………………………………………………….. 
 
 
Luogo……………………………………………………………..Data……………………………….. 
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SCHEDA RACCOLTA DATI 
Paziente 
 
Data_______________ 
 
NOME E COGNOME ____________________  N° Paziente __________________ 
DATA DI NASCITA ______________________________________________________ 
RECAPITO TELEFONICO __________________________________________________ 
STATO CIVILE  Nubile    
Coniugata/convivente  
Vedova    
Separata/divorziata  
N° FIGLI  _______________ ETA’ DEI FIGLI   ______   ______  ______ 
SCOLARITA’: 
Analfabeta  Alfabeta senza titolo di studio   Licenza elementare 
 Licenza media inferiore   Diploma   Laurea   
 
PROFESSIONE/OCCUPAZIONE:   
Occupata/o     Disoccupata/o                Casalinga   
Ritirata/o dal lavoro/Pensionata/o          Studente/ssa  
Altro   (specificare)  ____________________________ 
 
La paziente rifiuta di partecipare allo studio      
Motivo del rifiuto:_______________________________________________________________ 
Familiari presenti e grado di parentela:___________________________________________ 
 
CRITERI D’ESCLUSIONE 
La paziente ha un’età sotto i 18 o sopra i 75 anni      
La paziente non comprende bene la lingua italiana      
La paziente presenta metastasi (Tx, Nx, M1)      
La paziente presenta una recidiva (non è al primo episodio)    
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SCHEDA RACCOLTA DATI 
Familiare 
 
 
Data______________ 
 
NOME E COGNOME _______________________________      N° Paziente __________ 
DATA DI NASCITA _____________________ 
Sesso:  M  F 
STATO CIVILE  Nubile/Celibe 
Coniugato/a/Convivente 
Vedovo/a 
Separato/a/divorziato/a 
 
N° FIGLI  _______________ ETA’ ______  ______  ______ 
 
SCOLARITA’: 
Analfabeta  Alfabeta senza titolo di studio   Licenza elementare 
 Licenza media inferiore   Diploma    Laurea  
 
PROFESSIONE/OCCUPAZIONE:   
Occupata/o     Disoccupata/o                Casalinga   
Ritirata/o dal lavoro/Pensionata/o          Studente/ssa  
Altro   (specificare)  ____________________________ 
 
LEGAME DI PARENTELA CON LA PAZIENTE 
Marito     Figlio/a        Fratello/Sorella  Padre/Madre   
Cognato/Nuora   Cugino/a        Zio/a              Amico/a  
Altro  (Specificare) ____________________________ 
VIVE CON LA PAZIENTE   Sì    No   
Il familiare rifiuta di partecipare allo studio      
Motivo del rifiuto: ______________________________________________________________ 
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SCHEDA RACCOLTA DATI 
Oncologo 
 
Data______________ 
 
 
Iniziali della Paziente ____________   N° Paziente___________________ 
 
INFORMAZIONI RIGUARDANTI IL MEDICO  Iniziali___________________ codice_____ 
Età ________________ Anni d’esperienza lavorativa _____________  
Sesso: Maschio     Femmina   
 
PRESENZA ALTRO MEDICO  Iniziali___________________ codice_____ 
Età ________________ Anni d’esperienza lavorativa _____________  
Sesso: Maschio     Femmina   
________________________________________________________________________ 
PRESENZA MEDICO SPECIALIZZANDO      SI                   NO     
 
La paziente chiede di interrompere la registrazione durante la visita   
CRITERI D’ESCLUSIONE 
La paziente presenta metastasi (Tx, Nx, M1)      
La paziente presenta una recidiva (non è al primo episodio)    
La paziente non comprende bene la lingua italiana      
______________________________________________________________________________ 
La paziente non ha un cancro          
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INFORMAZIONI RIGUARDANTI LA PAZIENTE 
Da quanto tempo la paziente sa della propria malattia (giorni / mesi) __________ 
Chi ha informato la paziente della diagnosi: 
Medico di base   Chirurgo   Radiologo  Oncologo  
Altro medico (specificare) ____________________________ 
 
Data del I° intervento chirurgico effettuato:________________ 
Tipo d’intervento:   
Conservativo    Non conservativo  
Ricostruzione   sì    no   
Linfonodo sentinella:  sì    no   
Svuotamento ascellare:  sì    no   
IORT:    sì    no   
 
Stadio clinico di malattia attuale  
Stadiazione:  c (clinica)    p (patologica)  
Carcinoma Lobulare/Duttale in Situ: (LCIS)  (DCIS)  
T:  TX  T0  Tis T1  T2 T3  T4  
N:  NX  N0  N1  N2  N3  
M: MX M0 M1  
 
Patologie associate: 
Diabete      Ipertensione     
Osteoporosi       Iper/ipotiroidismo    
Ansia/Depressione     Altro_____________________ 
Terapia farmacologica in atto:_____________________________________________________ 
 
Menopausa   sì    no    
Rilevazione peso:      kg______      Rilevazione altezza:  cm_______ 
 
Piano terapeutico concordato con la paziente al termine della visita: 
Chemioterapia prevista sì    no    
Radioterapia prevista sì    no    
Ormonoterapia prevista sì    no    
Immunoterapia prevista sì    no    
Allargamento chirurgico sì    no    
Da rivalutare dopo ulteriori accertamenti  sì    no    
Svuotamento ascellare    sì    no    
Mastectomia      sì    no    
Altro________________________________________________ 
 
 
Eventuale prossima visita   no   si          data ______________ 
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QUESTIONARI PRE-COLLOQUIO 
 
 
 
 
 
 
 
 
 
 
N° paziente____________________ 
 
 
 
 
 
Data_______________ 
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STAI – X1  
 
Istruzioni: 
 
Sono di seguito riportate alcune frasi che le persone spesso usano per descriversi. Legga ciascuna frase e poi 
contrassegni con una crocetta la risposta come Lei si sente ADESSO, cioè in questo momento, mentre sta iniziando a 
compilare questo test. Non ci sono risposte giuste o sbagliate. Risponda a TUTTE le domande. Non impieghi troppo 
tempo per rispondere alle domande e scelga la sua risposta tra le seguenti: 
1 = PER NULLA                 2 = UN POCO                   3 = ABBASTANZA                  4 = MOLTISSIMO  
 
 
P
E
R
 N
U
L
L
A
 
U
N
 P
O
C
O
 
A
B
B
A
S
T
A
N
Z
A
 
M
O
L
T
IS
S
IM
O
 
1. Misentocalmo ………………………………………………. 
1 2 3 4 
2. Misentosicuro……..………………………………………… 
1 2 3 4 
3. Sonoteso……………………….....……………....................... 
1 2 3 4 
4. Hodeirimpianti……………………………………………… 
1 2 3 4 
5. Misentotranquillo…………………………………………… 
1 2 3 4 
6. Misentoturbato…….………………………………………... 
1 2 3 4 
7. Sono attualmente preoccupato per possibili disgrazie……. 
1 2 3 4 
8. Misento riposato...................................................................... 
1 2 3 4 
9. Misentoansioso……………………………………………… 
1 2 3 4 
10. Mi sento a mio agio………………..…………………………. 
1 2 3 4 
11. Mi sento sicuro di me………….…………………………….. 
1 2 3 4 
12. Misentonervoso…………….…............................................. 
1 2 3 4 
13. Son agitato …………………………………………………… 
1 2 3 4 
14. Misentomoltoteso………………………………………….. 
1 2 3 4 
15. Sonorilassato………………………..…………..................... 
1 2 3 4 
16. Misentocontento……………….…………………………… 
1 2 3 4 
17. Sonopreoccupato……………………………………………. 
1 2 3 4 
18. Mi sento sovraeccitato e scosso…………………………….. 
1 2 3 4 
19. Misento allegro……………………………………………… 
1 2 3 4 
20. Misentobene…………..…………………………………….. 
1 2 3 4 
 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
  1 
 
  1 
 
  1 
 
  1 
 
 1 
 
 1 
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DSES 
 
Qui sotto sono elencati alcuni aspetti importanti che riguardano il riuscire a prendere delle 
decisioni. 
 
Per favore indichi quanta fiducia ha in se stesso nel fare le seguenti cose, scegliendo un 
numero da 0 (per nulla fiducioso) a 4 (molto fiducioso) 
 
Mi sento fiducioso di: 
 
 Per 
nullafiduci
oso 
 
1 2 3 Molto 
fiducioso 
1. Riuscire ad ottenere le 
informazioni sulle varie 
medicine disponibili per me  
0 1 2 3 4 
2. Riuscire ad ottenere le 
informazioni rispetto ai benefici 
delle possibili cure 
0 1 2 3 4 
3. Riuscire ad ottenere le 
informazioni rispetto ai rischi e 
agli effetti collaterali delle cure 
0 1 2 3 4 
4. Comprendere le informazioni 
abbastanza per poter prendere 
una decisione 
0 1 2 3 4 
5. Porre domande senza sentirmi 
stupido 
 
0 1 2 3 4 
6. Esprimere le mie 
preoccupazioni rispetto alle 
possibili cure 
 
0 1 2 3 4 
7. Chiedere consigli 
 
 
0 1 2 3 4 
8. Riuscire a trovare le cure che 
si adattano di più a me 
 
0 1 2 3 4 
9. Gestire le eventuali pressioni 
di altri nella scelta delle cure 
 
0 1 2 3 4 
10. Far sapere a coloro che mi 
hanno in cura qual è la cosa 
migliore per me 
0 1 2 3 4 
11. Rimandare la decisione se 
sento di aver bisogno di più 
tempo 
 
0 1 2 3 4 
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GHQ-12 
 
 
Per favore leggete attentamente quanto segue e rispondete a tutte le domande. Rispondete con sincerità. I dati 
di questo questionario saranno tenuti riservati e saranno utilizzati solo per scopi statistici e scientifici. 
Vorremmo sapere se, durante le ultime settimane, avete avuto qualche disturbo di tipo medico e in 
generale come è il Vostro stato di salute. Rispondete, per favore, semplicemente mettendo una X sulla 
risposta che meglio si adatta a Voi. Ricordate che vorremmo conoscere i disturbi di cui soffrite o di cui avete 
sofferto recentemente (nelle ultime settimane), non i disturbi di molto tempo fa. 
Vi ringraziamo in anticipo per la vostra collaborazione. È importante che Voi tentiate di rispondere a tutte le 
domande. 
 
 
RECENTEMENTE: 
 
1. Avete perso molto sonno per    No  Non più     Un po’ più  Molto più 
delle preoccupazioni?     del solito     del solito  del solito 
 
2. Vi siete sentiti costantemente No   Non più      Un po’ più  Molto più 
sotto stress (tensione)?    del solito     del solito  del solito 
 
3. Siete stato in grado di   Meglio  Come al solito       Meno  Molto 
meno 
concentrarvi sulle cose   del solito         del solito  del solito 
che facevate?  
 
4. Vi siete sentiti utili?   Più del solito Come al solito      Meno utile  Molto 
meno 
         del solito  del solito 
 
5. Siete stato in grado di affrontare Più del solito Come al solito      Meno  Molto 
meno 
i vostri problemi?            del solito  del solito 
 
6. Vi siete sentiti capaci di   Più del solito Come al solito      Meno  Molto 
meno 
prendere decisioni?            del solito  del solito 
 
7. Avete avuto l’impressione di non No  Non più del solito   Un po’ più  Molto più 
essere in grado di superare le             del solito  del solito 
difficoltà?  
 
8.Vi siete sentiti, tutto sommato, Più del solito Circa come        Meno del solito           Molto meno  
abbastanza contenti?     al solito    del solito 
 
9. Siete stati in grado di svolgere Più del solito Come al solito          Meno  Molto 
meno 
volentieri le vostre attività  
quotidiane? 
 
10. Vi siete sentiti infelici o depressi? No  Non più        Un po’ più   Molto più 
       del solito       del solito  del solito 
 
11. Avete perso fiducia in voi stessi? No  Non più        Un po’ più  Molto più 
       del solito       del solito  del solito 
 
12. Avete pensato di essere  No  Non più       Un po’ più  Molto più 
una persona senza valore?    del solito       del solito  del solito 
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PHQ – 9   
 
Nelle ultime 2 settimane, con quale frequenza le ha dato fastidio ciascuno dei 
seguenti problemi? 
 
 
Mai 
 
Alcuni 
giorni 
 
Per più 
della 
metà del 
tempo 
Quasi 
ognigiorno 
1. Scarso interesse o piacere nel fare le cose     
2. Sentirsi giù, triste o disperato/a     
3. Problemi ad addormentarsi o a dormire tutta la 
notte senza svegliarsi, o a dormire troppo     
4. Sentirsi stanco/a o avere poca energia     
5. Scarso appetito o mangiare troppo     
6. Avere una scarsa opinione di sé, o sentirsi un 
fallimento o aver deluso se stesso/a o i propri 
familiari 
    
7. Difficoltà a concentrarsi su qualcosa, per 
esempio leggere il giornale o guardare la 
televisione 
    
8. Muoversi o parlare così lentamente da poter 
essere notato/a da altre persone. O, al contrario, 
essere così irrequieto/a da muoversi molto più 
del solito 
    
9. Pensare che sarebbe meglio morire o farsi del 
male in un modo o nell’altro     
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EPQ-R 
 
 
 
 
 
 
 
 
 
 
 
1. Ho frequenti sbalzi d’umore? ……………………………………………………………………….  SI        NO 
2. Sono una persona che parla volentieri? ……………………………………………………….  SI        NO 
3. Mi capita mai di sentirmi depresso senza alcuna ragione? …………………………..  SI        NO 
4. Sono piuttosto allegro di carattere?  ……………………………………………………………  SI        NO 
5. Mi irrito facilmente?  …………………………………………………………………………………..  SI        NO 
6. Mi piace incontrare gente nuova?  ………………………………………………………………  SI        NO 
7. Basta poco per ferire la mia sensibilità?  …………………………….……………………….  SI        NO 
8. In una festa animata, riesco in genere a lasciarmi andare, sentirmi a mio agio e   
divertirmi?  ……………………………………………………………………………………………………  SI        NO 
9. Ho spesso la sensazione di “non poterne proprio più”? ………………………………  SI        NO 
10. In generale, sono io a prendere l’iniziativa quando si tratta di fare amicizia con  
qualcuno?  …………………………………………………………………………………………………….  SI        NO 
11. Mi considero una persona nervosa?  …………………………………………………………..  SI        NO 
12. Sarei facilmente capace di animare una festa noiosa?  ……………………………….  SI        NO 
13. Mi preoccupo facilmente?  ………………………………………………………………………….  SI        NO 
14. Quando sto con la gente, tendo a starmene in disparte?  …………………………..  SI        NO 
15. Mi considero una persona tesa e nervosa?  ………………………………………………..  SI        NO 
16. Mi piace stare in mezzo alla gente?  ……………………………………………………………  SI        NO 
17. Mi preoccupo per troppo tempo, dopo un’esperienza imbarazzante?  ………  SI        NO 
18. Mi piace avere tanto movimento e animazione intorno a me?  ………………….  SI        NO 
19. Soffro di “nervi”?  ………………………………………………………………………..………….….  SI        NO 
20. Me ne sto per lo più in silenzio quando mi trovo con la gente? ………………..…  SI        NO 
21. Mi sento spesso solo?  …………………………………………………………………………....….  SI        NO 
22. La gente mi considera pieno di vitalità?  ……………………………………………….…….  SI        NO 
23. Ho spesso dei sensi di colpa?  ……………………………………………………………………..  SI        NO 
24. Sono capace di animare una festa?  …………………………………………………….……..  SI        NO 
Istruzioni: 
Le domande seguenti si riferiscono ad abitudini, comportamenti, tratti del carattere che una persona 
può avere. 
Non vi sono risposte giuste o sbagliate: quello che importa è che risponda a TUTTE le domande 
pensando effettivamente al suo usuale modo di essere e di comportarsi. 
La preghiamo di leggere attentamente una domanda alla volta e di scegliere la sua  risposta tra 
le seguenti:   SI       NO 
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CPS 
 
Per favore, tra le situazioni sotto rappresentate, indichi segnando con il numero “1” quella che, secondo lei meglio la rappresenta. Dopo aver 
escluso quella vignetta indichi anche una scelta alternativa indicandola con il numero “2”. 
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QUESTIONARI POST-COLLOQUIO 
 
 
 
 
 
 
 
 
 
 
N° paziente____________________ 
 
 
 
 
 
Data_______________ 
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SDM-9 
 
 
Per favore indichi quale decisione è stata presa durante l’ultima visita medica: 
________________________________________________________________________ 
________________________________________________________________________ 
 
 
Di seguito troverà nove frasi che descrivono come si è svolto l'incontro con l’oncologo per 
quanto riguarda le decisioni riguardo il trattamento delsul suo problema di salute. Per 
favore barri per ogni affermazione la casella più appropriata per lei. 
Faccia sempre riferimento a quanto le seguenti affermazioni corrispondono a ciò che 
è realmente accaduto durante la visita che ha appena effettuato con l’oncologo. 
 
 
Sì, 
esattamente 
Sì, 
 più o meno  
Più no  
che sì  
No,  
affatto 
 
1. L’oncologo mi ha comunicato 
chiaramente che deve essere presa 
una decisione 
    
2. L’oncologo voleva sapere da me 
esattamente come volessi 
partecipare alla decisione 
    
3. L’oncologo mi ha comunicato che 
esistono diverse possibilità di 
trattamento per i miei disturbi 
    
4. L’oncologo mi ha spiegato 
esattamente vantaggi e svantaggi 
delle diverse possibilità di 
trattamento 
    
5. L’oncologo mi ha aiutato a capire 
tutte le informazioni 
    
6. L’oncologo mi ha chiesto quale 
possibile trattamento preferissi 
    
7. L’oncologo ed io abbiamo valutato 
accuratamente le diverse possibilità 
di trattamento 
    
8. L’oncologo ed io abbiamo scelto 
insieme un trattamento 
    
9. L’oncologo ed io abbiamo trovato un 
accordo su come procedere in 
seguito 
    
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PEI 
 
 
Dopo la visita di oggi con il medico mi sento: 
 
 
  
Molto di 
più 
 
Di più 
Uguale 
o meno 
Non 
applica-
bile 
1. Capace di affrontare la vita 
    
2. Capace di capire la mia malattia 
    
3. Capace di affrontare la mia malattia 
    
4. Capace di mantenermi in buona 
salute 
    
5. Fiducioso rispetto alla mia salute 
    
6. Capace di poter contare su me 
stesso 
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SWD 
 
Per favore indichi quanto si sente d’accordo con le seguenti affermazioni 
riguardanti le decisioni terapeutiche prese durante la visita di oggi. 
 
 
 Fortemente in 
disaccordo 
 
 
(1) 
Disaccordo 
 
 
 
(2) 
Neutro 
 
 
 
(3) 
D’accordo 
 
 
 
(4) 
Completa-
mente 
d’accordo 
 
(5) 
1. Sono stato adeguatamente 
informato rispetto alle 
possibili cure disponibili per 
la mia malattia 
     
2. La decisione presa secondo 
me è la migliore per il mio 
caso 
     
3. La decisione presa è in 
linea con i miei valori 
     
4. Mi aspetto di portare avanti 
la decisione presa con 
successo 
     
5. Ho avuto le informazioni che 
desideravo per la scelta 
delle cure 
     
6. Sono soddisfatto della 
decisione presa rispetto alle 
cure 
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PDRQ-9  
 
Leggerà 9 affermazioni che un paziente può fare rispetto all’oncologo che l’ha 
visitata oggi.  
Per favore indichi quanto è appropriata ognuna delle seguenti affermazioni riguardo 
all’oncologo che l’ha visitata oggi. 
 
 Per 
nullaappro
priato 
 
(1) 
Pocoapprop
riato 
 
(2) 
Appropriato 
 
 
(3) 
Abbastanza
appropriato 
 
(4) 
Completamentea
ppropriato 
 
(5) 
1. L’oncologo mi ha aiutata      
2. L’oncologo mi ha 
dedicato abbastanza 
tempo 
     
3. Ho fiducia nell’oncologo      
4. L’oncologo mi ha capito      
5. L’oncologo si è mostrato 
disponibile ad aiutarmi 
     
6. Io e l’oncologo siamo 
d’accordo sulla natura 
dei miei sintomi 
     
7. E’ facile parlare con 
l’oncologo  
     
8. Sono soddisfatto del 
trattamento medico 
ricevuto  
     
9. Trovo il servizio 
facilmente accessibile 
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Recall 
 
 Per nulla Poco Abbastanza Molto Moltissimo 
1. Secondo lei l’oncologo 
quanto è riuscito a rispondere 
in maniera chiara e completa 
alle sue domande? 
 
     
2. Quanto sente il bisogno di 
ricevere altre informazioni oltre 
a quelle ricevute oggi? 
     
 
3. È stato deciso quali saranno 
le sue cure? 
SI                              NO       
4. Di quali terapie Le ha 
parlato l’oncologo? 
____________________________________________ 
____________________________________________ 
 
5. Quali informazioni Le ha dato 
l’oncologo su come si svolgerà 
la sua terapia, per esempio 
durata, frequenza, modalità di 
somministrazione (es. farmaci 
endovena, per bocca, durata, 
ecc)? 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
6. Quali informazioni Le ha dato 
l’oncologo sui possibili effetti 
collateraliindesiderati delle 
cure? 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
7. Quali informazioni Le ha dato 
l’oncologo su cosa si può fare 
per controllare e ridurre i 
possibilieffetti collaterali delle 
cure? 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
 
8. Quali informazioni Le ha dato 
l’oncologo su quanto sono 
efficaci le terapie nel curare e 
controllare la sua malattia? 
 
____________________________________________ 
____________________________________________ 
____________________________________________ 
9. L’oncologo le ha consigliato 
delle visite di controllo? Se si, 
di che tipo e con che 
frequenza? 
____________________________________________ 
____________________________________________ 
____________________________________________ 
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STAI – X1/R  
 
Istruzioni: 
 
Legga ciascuna frase e poi contrassegni la risposta che indica come lei sis sente ADESSO, cioè in questo momento, ora 
che ha completato i suoi test. Risponda a TUTTE le domande. Scelga la risposta che le sembra meglio descrivere il suo 
stato d’animo ATTUALE. Scelga tra le seguenti risposte: 
 
1 = PER NULLA                 2 = UN POCO                   3 = ABBASTANZA                  4 = MOLTISSIMO  
 
 
P
E
R
 N
U
L
L
A
 
U
N
 P
O
C
O
 
A
B
B
A
S
T
A
N
Z
A
 
M
O
L
T
IS
S
IM
O
 
1. Misentocalmo……………………………………………… 
1 2 3 4 
2. Sonoteso……………………….....…………………………. 
1 2 3 4 
3. Misentotranquillo…………………………………………. 
1 2 3 4 
4. Misentoturbato…….……………………………………… 
1 2 3 4 
5. Misento riposato.................................................................... 
1 2 3 4 
6. Misentoansioso……………………………………………. 
1 2 3 4 
7. Misentonervoso…………….…............................................ 
1 2 3 4 
8. Son agitato ………………………………………………….. 
1 2 3 4 
9. Sonopreoccupato…………………………………………… 
1 2 3 4 
10. Misentobene…………..…………………………………… 
1 2 3 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
  1 
 
  1 
 
  1 
 
  1 
 
 1 
 
 1 
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APPENDIX C 
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QUESTIONARI PRE-COLLOQUIO  
Familiare F 
 
 
 
 
 
 
 
 
 
 
 
N° paziente____________________ 
 
 
 
 
 
Data_______________ 
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STAI – X1 – Familiare 
 
Istruzioni: 
 
Sono di seguito riportate alcune frasi che le persone spesso usano per descriversi. Legga ciascuna frase e poi 
contrassegni con una crocetta la risposta come Lei si sente ADESSO, cioè in questo momento, mentre sta iniziando a 
compilare questo test. Non ci sono risposte giuste o sbagliate. Risponda a TUTTE le domande. Non impieghi troppo 
tempo per rispondere alle domande e scelga la sua risposta tra le seguenti: 
1 = PER NULLA                 2 = UN POCO                   3 = ABBASTANZA                  4 = MOLTISSIMO  
 
 
P
E
R
 N
U
L
L
A
 
U
N
 P
O
C
O
 
A
B
B
A
S
T
A
N
Z
A
 
M
O
L
T
IS
S
IM
O
 
1. Misentocalmo ………………………………………………. 
1 2 3 4 
2. Misentosicuro……..………………………………...……… 
1 2 3 4 
3. Sonoteso……………………….....……………....................... 
1 2 3 4 
4. Hodeirimpianti……………………………………………… 
1 2 3 4 
5. Misentotranquillo…………………………………………… 
1 2 3 4 
6. Misentoturbato…….………………………………………... 
1 2 3 4 
7. Sono attualmente preoccupato per possibili disgrazie……. 
1 2 3 4 
8. Misento riposato...................................................................... 
1 2 3 4 
9. Misentoansioso……………………………………………… 
1 2 3 4 
10. Mi sento a mio agio………………..…………………………. 
1 2 3 4 
11. Mi sento sicuro di me………….…………………………….. 
1 2 3 4 
12. Misentonervoso…………….…............................................. 
1 2 3 4 
13. Son agitato …………………………………………………… 
1 2 3 4 
14. Misentomoltoteso………………………………………….. 
1 2 3 4 
15. Sonorilassato………………………..…………..................... 
1 2 3 4 
16. Misentocontento……………….…………………………… 
1 2 3 4 
17. Sonopreoccupato……………………………………………. 
1 2 3 4 
18. Mi sento sovraeccitato e scosso…………………………….. 
1 2 3 4 
19. Misento allegro……………………………………………… 
1 2 3 4 
20. Misentobene…………..…………………………………….. 
1 2 3 4 
 
 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
  1 
 
  1 
 
  1 
 
  1 
 
 1 
 
 1 
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DSES - Familiare 
 
 
Qui sotto sono elencati alcuni aspetti importanti che riguardano il riuscire a prendere delle 
decisioni. 
 
Per favore indichi quanta fiducia ha in se stesso nel fare le seguenti cose, scegliendo un 
numero da 0 (per nulla fiducioso) a 4 (molto fiducioso) 
 
Mi sento fiducioso di: 
 
 Per 
nullafiduci
oso 
 
1 2 3 Molto 
fiducioso 
1. Riuscire ad ottenere le 
informazioni sulle varie 
medicine disponibili per il mio 
familiare  
0 1 2 3 4 
2. Riuscire ad ottenere le 
informazioni rispetto ai 
benefici delle possibili cure 
0 1 2 3 4 
3. Riuscire ad ottenere le 
informazioni rispetto ai rischi 
e agli effetti collaterali delle 
cure 
0 1 2 3 4 
4. Comprendere le informazioni 
abbastanza per poter 
prendere una decisione 
0 1 2 3 4 
5. Porre domande senza 
sentirmi stupido 
 
0 1 2 3 4 
6. Esprimere le mie 
preoccupazioni rispetto alle 
possibili cure 
 
0 1 2 3 4 
7. Chiedere consigli 
 
 
0 1 2 3 4 
8. Riuscire a trovare le cure che 
si adattano di più al mio 
familiare 
 
0 1 2 3 4 
9. Gestire le eventuali pressioni 
di altri nella scelta delle cure 
 
0 1 2 3 4 
10. Far sapere a coloro che 
hanno in cura il mio familiare 
qual è la cosa migliore per lui 
0 1 2 3 4 
11. Rimandare la decisione se 
sentiamo di aver bisogno di 
più tempo 
 
0 1 2 3 4 
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GHQ-12 - Familiare 
 
 
Per favore leggete attentamente quanto segue e rispondete a tutte le domande. Rispondete con sincerità. I dati 
di questo questionario saranno tenuti riservati e saranno utilizzati solo per scopi statistici e scientifici. 
Vorremmo sapere se, durante le ultime settimane, avete avuto qualche disturbo di tipo medico e in 
generale come è il Vostro stato di salute. Rispondete, per favore, semplicemente mettendo una X sulla 
risposta che meglio si adatta a Voi. Ricordate che vorremmo conoscere i disturbi di cui soffrite o di cui avete 
sofferto recentemente (nelle ultime settimane), non i disturbi di molto tempo fa. 
Vi ringraziamo in anticipo per la Vostra collaborazione. È importante che Voi tentiate di rispondere a tutte le 
domande. 
 
 
RECENTEMENTE: 
 
1. Avete perso molto sonno per    No  Non più     Un po’ più  Molto più 
delle preoccupazioni?     del solito     del solito  del solito 
 
2. Vi siete sentiti costantemente No   Non più      Un po’ più  Molto più 
sotto stress (tensione)?    del solito     del solito  del solito 
 
3. Siete stato in grado di   Meglio  Come al solito       Meno  Molto 
meno 
concentrarvi sulle cose   del solito         del solito  del solito 
che facevate?  
 
4. Vi siete sentiti utili?   Più del solito Come al solito      Meno utile  Molto 
meno 
         del solito  del solito 
 
5. Siete stato in grado di affrontare Più del solito Come al solito      Meno  Molto 
meno 
i vostri problemi?            del solito  del solito 
 
6. Vi siete sentiti capaci di   Più del solito Come al solito      Meno  Molto 
meno 
prendere decisioni?            del solito  del solito 
 
7. Avete avuto l’impressione di non No  Non più del solito   Un po’ più  Molto più 
essere in grado di superare le             del solito  del solito 
difficoltà?  
 
8.Vi siete sentiti, tutto sommato, Più del solito Circa come        Meno del solito           Molto meno  
abbastanza contenti?     al solito    del solito 
 
9. Siete stati in grado di svolgere Più del solito Come al solito          Meno  Molto 
meno 
volentieri le vostre attività  
quotidiane? 
 
10. Vi siete sentiti infelici o depressi? No  Non più        Un po’ più   Molto più 
       del solito       del solito  del solito 
 
11. Avete perso fiducia in voi stessi? No  Non più        Un po’ più  Molto più 
       del solito       del solito  del solito 
 
12. Avete pensato di essere  No  Non più       Un po’ più  Molto più 
una persona senza valore?    del solito       del solito  del solito 
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PHQ – 9 - Familiare  
 
 
Nelle ultime 2 settimane, con quale frequenza le ha dato fastidio ciascuno dei 
seguenti problemi? 
 
 
Mai 
 
Alcuni 
giorni 
 
Per più 
della 
metà del 
tempo 
Quasi 
ognigiorno 
1. Scarso interesse o piacere nel fare le cose     
2. Sentirsi giù, triste o disperato/a     
3. Problemi ad addormentarsi o a dormire tutta la 
notte senza svegliarsi, o a dormire troppo     
4. Sentirsi stanco/a o avere poca energia     
5. Scarso appetito o mangiare troppo     
6. Avere una scarsa opinione di sé, o sentirsi un 
fallimento o aver deluso se stesso/a o i propri 
familiari 
    
7. Difficoltà a concentrarsi su qualcosa, per 
esempio leggere il giornale o guardare la 
televisione 
    
8. Muoversi o parlare così lentamente da poter 
essere notato/a da altre persone. O, al 
contrario, essere così irrequieto/a da muoversi 
molto più del solito 
    
9. Pensare che sarebbe meglio morire o farsi del 
male in un modo o nell’altro     
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EPQ-R 
 
 
 
 
 
 
 
 
 
 
 
1. Ho frequenti sbalzi d’umore? ……………………………………………………………………….  SI        NO 
2. Sono una persona che parla volentieri? ……………………………………………………….  SI        NO 
3. Mi capita mai di sentirmi depresso senza alcuna ragione? …………………………..  SI        NO 
4. Sono piuttosto allegro di carattere?  ……………………………………………………………  SI        NO 
5. Mi irrito facilmente?  …………………………………………………………………………………..  SI        NO 
6. Mi piace incontrare gente nuova?  ………………………………………………………………  SI        NO 
7. Basta poco per ferire la mia sensibilità?  …………………………….……………………….  SI        NO 
8. In una festa animata, riesco in genere a lasciarmi andare, sentirmi a mio agio e   
divertirmi?  ……………………………………………………………………………………………………  SI        NO 
9. Ho spesso la sensazione di “non poterne proprio più”? ………………………………  SI        NO 
10. In generale, sono io a prendere l’iniziativa quando si tratta di fare amicizia con  
qualcuno?  …………………………………………………………………………………………………….  SI        NO 
11. Mi considero una persona nervosa?  …………………………………………………………..  SI        NO 
12. Sarei facilmente capace di animare una festa noiosa?  ……………………………….  SI        NO 
13. Mi preoccupo facilmente?  ………………………………………………………………………….  SI        NO 
14. Quando sto con la gente, tendo a starmene in disparte?  …………………………..  SI        NO 
15. Mi considero una persona tesa e nervosa?  ………………………………………………..  SI        NO 
16. Mi piace stare in mezzo alla gente?  ……………………………………………………………  SI        NO 
17. Mi preoccupo per troppo tempo, dopo un’esperienza imbarazzante?  ………  SI        NO 
18. Mi piace avere tanto movimento e animazione intorno a me?  ………………….  SI        NO 
19. Soffro di “nervi”?  ………………………………………………………………………..………….….  SI        NO 
20. Me ne sto per lo più in silenzio quando mi trovo con la gente? ………………..…  SI        NO 
21. Mi sento spesso solo?  …………………………………………………………………………....….  SI        NO 
22. La gente mi considera pieno di vitalità?  ……………………………………………….…….  SI        NO 
23. Ho spesso dei sensi di colpa?  ……………………………………………………………………..  SI        NO 
24. Sono capace di animare una festa?  …………………………………………………….……..  SI        NO
Istruzioni: 
Le domande seguenti si riferiscono ad abitudini, comportamenti, tratti del carattere che una persona 
può avere. 
Non vi sono risposte giuste o sbagliate: quello che importa è che risponda a TUTTE le domande 
pensando effettivamente al suo usuale modo di essere e di comportarsi. 
La preghiamo di leggere attentamente una domanda alla volta e di scegliere la sua  risposta tra 
le seguenti:   SI       NO 
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CPS 
 
Per favore, tra le situazioni sotto rappresentate, indichi segnando con il numero “1” quella che, secondo lei meglio la rappresenta. Dopo aver 
escluso quella vignetta indichi anche una scelta alternativa indicandola con il numero “2”. 
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QUESTIONARI POST-COLLOQUIO 
FAMILIARE 
 
 
 
 
 
 
 
 
 
 
N° paziente____________________ 
 
 
 
 
 
Data_______________ 
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SDM-9 - Familiare 
 
 
Per favore indichi quale decisione è stata presa durante l’ultima visita medica: 
________________________________________________________________________ 
________________________________________________________________________ 
 
 
Di seguito troverà nove frasi che descrivono come si è svolto l'incontro con l’oncologo per 
quanto riguarda le decisioni riguardo il trattamento del problema di salute del suo 
familiare.  
Per favore barri per ogni affermazione la casella più appropriata per lei. 
Faccia sempre riferimento a quanto le seguenti affermazioni corrispondono a ciò che 
è realmente accaduto durante la visita appena effettuatacon l’oncologo. 
 
 
Sì, 
esattamente 
Sì, 
 più o meno  
Più no  
che sì  
No,  
affatto 
 
1. L’oncologo ha comunicato 
chiaramente che deve essere presa 
una decisione 
    
2. L’oncologo voleva sapere 
esattamente come il mio familiare 
volesse partecipare alla decisione 
    
3. L’oncologo ha comunicato che 
esistono diverse possibilità di 
trattamento 
    
4. L’oncologo ha spiegato esattamente 
vantaggi e svantaggi delle diverse 
possibilità di trattamento 
    
5. L’oncologo ha aiutato a capire tutte 
le informazioni 
    
6. L’oncologo ha chiesto quale 
possibile trattamento preferisse il 
mio familiare 
    
7. L’oncologo ha valutato 
accuratamente con il mio familiare le 
diverse possibilità di trattamento 
    
8. L’oncologo ha scelto insieme al mio 
familiare un trattamento 
    
9. L’oncologo ha trovato un accordo 
con il mio familiare su come 
procedere in seguito 
    
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PEI - Familiare 
 
 
Dopo la visita di oggi con il medico mi sento: 
 
 
  
Molto di 
più 
 
Di più 
Uguale 
o meno 
Non 
applica-
bile 
1. Capace di affrontare la vita 
    
2. Capace di capire la malattia del 
mio familiare 
    
3. Capace di affrontare la malattia del 
mio familiare 
    
4. Capace di mantenermi in buona 
salute 
    
5. Fiducioso rispetto alla mia salute e 
del mio familiare  
    
6. Capace di poter contare su me 
stesso 
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SWD - Familiare 
 
 
Per favore indichi quanto si sente d’accordo con le seguenti affermazioni 
riguardanti le decisioni terapeutiche prese durante la visita di oggi. 
 
 
 Fortemente in 
disaccordo 
 
 
(1) 
Disaccordo 
 
 
 
(2) 
Neutro 
 
 
 
(3) 
D’accordo 
 
 
 
(4) 
Completa-
mente 
d’accordo 
 
(5) 
1. Ritengo che il mio familiare 
sia stato adeguatamente 
informato rispetto alle 
possibili cure disponibili per 
la sua malattia 
     
2. La decisione presa, secondo 
me è la migliore per il suo 
caso 
     
3. La decisione presa è in linea 
con i suoi valori 
     
4. Mi aspetto che porterà avanti 
la decisione presa con 
successo 
     
5. Ritengo che il mio familiare 
abbia avuto le informazioni 
che desiderava per la scelta 
delle cure 
     
6. Ritengo che il mio familiare 
sia soddisfatto della 
decisione presa rispetto alle 
cure 
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 PDRQ-9 - Familiare 
 
 
Leggerà 9 affermazioni che un paziente può fare rispetto all’oncologo che ha 
visitato oggi il suo familiare.  
Per favore indichi quanto è appropriata ognuna delle seguenti affermazioni riguardo 
all’oncologo che ha visitato oggi il suo familiare. 
 
 Per 
nullaappro
priato 
 
(1) 
Pocoapprop
riato 
 
(2) 
 
Appropriato 
 
(3) 
Abbastanza
appropriato 
 
(4) 
Completamentea
ppropriato 
 
(5) 
1. L’oncologo ha aiutato il 
mio familiare 
     
2. L’oncologo ha dedicato 
al mio familiare 
abbastanza tempo 
     
3. Ho fiducia nell’oncologo      
4. L’oncologo ha capito il 
mio familiare 
     
5. L’oncologo si è mostrato 
disponibile ad aiutare il 
mio familiare 
     
6. L’oncologo ed il mio 
familiare sono d’accordo 
sulla natura dei suoi 
sintomi 
     
7. E’ facile parlare con 
l’oncologo 
     
8. Sono soddisfatto del 
trattamento medico 
ricevuto dal mio familiare 
     
9. Trovo il servizio 
facilmente accessibile 
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Recall - Familiare 
 
 Per nulla Poco Abbastanza Molto Moltissimo 
1. Secondo lei l’oncologo 
quanto è riuscito a rispondere 
in maniera chiara e completa 
alle sue domande? 
 
     
2. Quanto sente il bisogno di 
ricevere altre informazioni oltre 
a quelle ricevute oggi? 
     
 
3. È stato deciso quali saranno 
le cure del suo familiare? 
SI                              NO       
4. Di quali terapie ha parlato 
l’oncologo? 
____________________________________________ 
____________________________________________ 
 
5. Quali informazioni ha dato 
l’oncologo su come si svolgerà 
la terapia del suo familiare, per 
esempio durata, frequenza, 
modalità di somministrazione 
(es. farmaci endovena, per 
bocca, durata, etc)? 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
6. Quali informazioni ha dato 
l’oncologo sui possibili effetti 
collateraliindesiderati delle 
cure? 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
7. Quali informazioni ha dato 
l’oncologo su cosa si può fare 
per controllare e ridurre i 
possibilieffetti collaterali delle 
cure? 
____________________________________________ 
____________________________________________ 
____________________________________________ 
____________________________________________ 
 
8. Quali informazioni ha dato 
l’oncologo su quanto sono 
efficaci le terapie nel curare e 
controllare la malattia del suo 
familiare? 
 
____________________________________________ 
____________________________________________ 
____________________________________________ 
9. L’oncologo ha consigliato 
delle visite di controllo? Se si, 
di che tipo e con che 
frequenza? 
____________________________________________ 
____________________________________________ 
____________________________________________ 
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STAI – X1/R  
 
Istruzioni: 
 
Legga ciascuna frase e poi contrassegni la risposta che indica come lei sis sente ADESSO, cioè in questo momento, ora 
che ha completato i suoi test. Risponda a TUTTE le domande. Scelga la risposta che le sembra meglio descrivere il suo 
stato d’animo ATTUALE. Scelga tra le seguenti risposte: 
 
1 = PER NULLA                 2 = UN POCO                   3 = ABBASTANZA                  4 = MOLTISSIMO  
 
 
P
E
R
 N
U
L
L
A
 
U
N
 P
O
C
O
 
A
B
B
A
S
T
A
N
Z
A
 
M
O
L
T
IS
S
IM
O
 
1. Misentocalmo……………………………………………... 
1 2 3 4 
2. Sonoteso……………………….....…………………………. 
1 2 3 4 
3. Misentotranquillo…………………………………………. 
1 2 3 4 
4. Misentoturbato…….……………………………………… 
1 2 3 4 
5. Misento riposato.................................................................... 
1 2 3 4 
6. Misentoansioso……………………………………………. 
1 2 3 4 
7. Misentonervoso…………….…............................................ 
1 2 3 4 
8. Son agitato ………………………………………………….. 
1 2 3 4 
9. Sonopreoccupato…………………………………………… 
1 2 3 4 
10. Misentobene…………..…………………………………… 
1 2 3 4 
 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
 1 
 
 1 
 
 1 
 
  1 
 
  1 
 
 1 
 
 1 
 
  1 
 
  1 
 
  1 
 
  1 
 
 1 
 
 1 
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CPS - M 
 
 
Per favore, tra le situazioni sotto rappresentate, indichi quella che, secondo lei ha scelto la 
paziente che ha appena visitato.  
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DDPRQ-10  
 
 
Per favore risponda ad ognuna delle domande seguenti secondo la scala dove 1 indica per 
nulla, e 6 moltissimo. Tenga presente che non ci sono risposte giuste o sbagliate. 
 
 Per nulla 
(1) 
 
(2) 
 
(3) 
 
(4) 
 
(5) 
Moltissimo 
(6) 
1. Dopo la visita di oggi, 
quanto desidera rivedere 
questa paziente la prossima 
volta? 
○ ○ ○ ○ ○ ○ 
2. Quanto “frustrante” trova 
questa paziente? ○ ○ ○ ○ ○ ○ 
3. Quanto è manipolativa 
questa paziente? ○ ○ ○ ○ ○ ○ 
4. In che misura si sente 
frustrato dalle vaghe 
lamentele della paziente? 
○ ○ ○ ○ ○ ○ 
5. Quanto le sembra 
autodistruttiva questa 
paziente? 
○ ○ ○ ○ ○ ○ 
6. Si ritrova a nutrire 
segretamente la speranza 
che questa paziente non 
ritorni? 
○ ○ ○ ○ ○ ○ 
7. Quanto si è sentito a suo 
agio mentre era con questa 
paziente oggi? 
○ ○ ○ ○ ○ ○ 
8. Quanto tempo porta via il 
prendersi cura di questa 
paziente? 
○ ○ ○ ○ ○ ○ 
9. Quanto è piacevole 
prendersi cura di questa 
paziente? 
○ ○ ○ ○ ○ ○ 
10. Quanto è difficile la 
comunicazione con questa 
paziente? 
○ ○ ○ ○ ○ ○ 
11. Quanto impegnativo è stato 
rispondere alle domande di 
questa paziente? 
○ ○ ○ ○ ○ ○ 
12. Quanto la paziente le è 
sembrata ansiosa o 
preoccupata per la propria 
salute? 
○ ○ ○ ○ ○ ○ 
 
 
13. Questa 
paziente le è 
sembrata 
depressa?  
 
○ sì:○lievemente○ moderatamente○ gravemente 
○ no                                                              
 
14. La paziente ha 
manifestato un 
disagio emotivo 
durante il 
colloquio? 
○ sì:       ○lieve○ moderato              ○ grave 
○ no                                                              
 
